WO2008043044A2 - Devices and methods for endoluminal gastric restriction tissue manipulation, and drug delivery - Google Patents

Devices and methods for endoluminal gastric restriction tissue manipulation, and drug delivery Download PDF

Info

Publication number
WO2008043044A2
WO2008043044A2 PCT/US2007/080485 US2007080485W WO2008043044A2 WO 2008043044 A2 WO2008043044 A2 WO 2008043044A2 US 2007080485 W US2007080485 W US 2007080485W WO 2008043044 A2 WO2008043044 A2 WO 2008043044A2
Authority
WO
WIPO (PCT)
Prior art keywords
plication
lumen
wall
patient
tissue
Prior art date
Application number
PCT/US2007/080485
Other languages
French (fr)
Other versions
WO2008043044A3 (en
WO2008043044A8 (en
Inventor
Michael D. Laufer
Thomas Bromander
Amos Cruz
Original Assignee
Ndo Surgical, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ndo Surgical, Inc. filed Critical Ndo Surgical, Inc.
Priority to EP07843869A priority Critical patent/EP2076183A4/en
Priority to CN200780041843.4A priority patent/CN101795627A/en
Publication of WO2008043044A2 publication Critical patent/WO2008043044A2/en
Publication of WO2008043044A3 publication Critical patent/WO2008043044A3/en
Publication of WO2008043044A8 publication Critical patent/WO2008043044A8/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0401Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/00234Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0469Suturing instruments for use in minimally invasive surgery, e.g. endoscopic surgery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00004(bio)absorbable, (bio)resorbable, resorptive
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00743Type of operation; Specification of treatment sites
    • A61B2017/00818Treatment of the gastro-intestinal system
    • A61B2017/00827Treatment of gastro-esophageal reflux
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00831Material properties
    • A61B2017/00867Material properties shape memory effect
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0401Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
    • A61B2017/0404Buttons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0401Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
    • A61B2017/0417T-fasteners
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0469Suturing instruments for use in minimally invasive surgery, e.g. endoscopic surgery
    • A61B2017/0472Multiple-needled, e.g. double-needled, instruments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B2017/0496Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials for tensioning sutures
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
    • A61F5/0003Apparatus for the treatment of obesity; Anti-eating devices
    • A61F5/0013Implantable devices or invasive measures
    • A61F5/0083Reducing the size of the stomach, e.g. gastroplasty
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/10X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/1001X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy

Definitions

  • J the present invention is related to endoluminal surgical devices, methods, device, a
  • Laparoscopic surgery has greatly reduced the size and scope of incisions made in a patient and resulted in reduced morbidity and mortality rates.
  • a technique that is developing to further reduce surgical complications is to work through an endoluminal access port.
  • One endoluminal access port is the mouth and this access port can give a surgeon access to a patient's esophagus and stomach.
  • Stomach tigsue often needs surgical treatment to treat fistulas and to close transgastric incisic ns to stop stomach fluids from leaking from the stomach to surrounding tissue and to stop infectious matter from spreading from or to the stomach tissue.
  • Other ston ach treatments include stomach reduction procedures for obese patients.
  • physicians have been placing devices such as the Lap Band® on the external surface of the gastric wall to create a restricted stomach capacity.
  • Another traditional procedure for stomach reduction includes a laparoscopic procedure in which surgeons protrude into the stomach from the exterior of the patient and staple the stomach into a smaller volume. This restriction creates a pouch inside the stomach which fills quickly when food is ingested and assists in generating a sensation of being full.
  • these procedures have drawbacks such as complications from port punctures of the stomach, large- incisions, substantial recovery time, expense, lost productive work time, infection, and the like.
  • the incision required by the current surgical procedures include a morbidity and mortality rate that can be reduced by reducing or eliminating the need for an incision by approaching the surgical site through endoluminal procedures.
  • the present invention includes an implant device including a medical implant configured to be implanted into a lumen of a body without creating an incision in the body, wherein the medical implant is configured to maintain a plication in a wall of the lumen and wherein the medical implant includes a medical treatment.
  • the mfdical treatment can include a drug delivery, a time released drug delivery, a coating, a biological stimulation device, a monitoring device, a feeding tube, a bioresorbable material, and combinations thereof.
  • the biological stimulation device can be selected from the group consisting of an electrical stimulation device, mechanical stimulation device;, vibratory device, sound device, ultra-sound device, chemical stimulatory device, neurotransmitter stimulation device, thermal stimulation, sensory stimulatory device, and combinations thereof.
  • the implant device further includes a controller configured to control the biological stimulation device.
  • the controller can control the biological stimulation device from external to the body and through radio frequency.
  • the monitoring device can be selected from the group of a pH sensor, pressure sensor, video sensor, chemical sensor, hormone sensor, dilation sensor, fluid sensor, ion sensor, tissue extension sensor, and combinations thereof.
  • the medical treatment includes material selected from radioactive material, chemotherapy material, biological materia , and combinations thereof.
  • the medical treatment is configured to treat a gastric condition.
  • the medical implant is includes bioresorbable material including a drug.
  • an endoscopic treatment method includes introducing an endoscopic device into a lumen of a patient without creating an incision in the patient, engaging a wall of the lumen with an end effecter of the endoscopic device to form a plication, and activating the end effecter to secure the plication with an anchor object and a treatment device, wherein the treatment device is coupled with the anchor object.
  • an endoscopic treatment method includes introducing an endoscopic device into a lumen of a patient without creating an incision in the patient, introducing a treatment device into the lumen, engaging a wall of the lumen with an end effecter of the endoscopic device, forming a first plication in the wall of the lumen, forming a second plication in the wall of the lumen adjacent the first plication, and coupling the first plication with the second plication to thereby form a first double plication wherein an open pocket is formed between the first plication and the second plication.
  • the method includes forming a second double plication adjacent the first double plication, wherein a second open pocket formed by the second double pliqation and the open pocked formed by the first double plication are axially aligned.
  • the method includes forming an artificial biological tube bylaligning multiple double plications such that open pockets formed by the multiple double plications axially align.
  • the method includes coupling the first double plication with the second double plication.
  • an endoscopic GERD treatment method includes introducing an endoscopic device into a lumen of a patient without creating an incision in the patient, engaging a wall of the lumen with an end effecter of the endoscopic device ⁇ and forming a plication in the wall of the lumen near the gastroesophageal -junction such that an artificial biologic tube is formed distal to the gastroesophageal -juncticjn to block gastric fluid from interfering with tissue of the esophagus.
  • the method includes forming a plurality of plications extending distally from the gbstro-esophageal-junction.
  • the artificial biologic tube is be
  • an endoscopic obesity treatment method includes introducing an endoscopic device into a stomach of a patient without creating an incision in the patient, engaging a wall of the stomach with an end effecter of the endoscopic device, and forming a plication in the wall of the stomach such that an artificial biologic tube is formed wi ⁇ in the stomach of the patient and thereby reducing a volume of the stomach to treat obesity.
  • a medical implant apparatus includes an anchor object configured ;o couple with tissue and an adjustable mechanism configured to interact with the anchor object such as to apply alternative forces upon the anchor object in response to a stimulus.
  • the adjustable mechanism is coupled with the anchor object through suture material.
  • the adjustable mechanism is coupled with the anchor object through surgical wire.
  • the adjustable mechanism shortens in response to a stimuli.
  • the adjustable mechanism includes a mechanism selected from the group consisting of: piezoelectric, magnetic, screw-threads, spring, memory metal, elastic, mechanical mechanism, temperature sensitive material, and combinations thereof.
  • the stimuli is selected from the group of a radio frequency, ultra-sound, mechanical force, pressure, direct mechanical manipulation, magnetic force, chemical interaction, enzyme interaction, fluid, temperature, biological fluid, cellular interaction, cellular by-product, inter-cellular constituent, intra-cellular constituent, food, digestion by-product, a lapse of time, and combinations thereof.
  • the device further includes a plurality of anchor objects wherein each anchor object is ccupled with the adjustable mechanism such that an adjustable substantially sphincter shaped tissue structure is formed.
  • a method for temporary tissue restructuring includes implanting an anchor object onto tissue to be adjustably restructured, associating an adjustable mechanism with the anchor object such that a force generated by the adjustable mechanjism can change a relative position of the anchor object with respect to the adjustable medhanism and thereby restructures tissue, and stimulating the adjustable mechanism to generate the force.
  • the method further includes a plurality of anchor objects, wherein each anchor object is coupled with the adjustable mechanism. The plurality of anchor objects can be coupled in series with the adjustable mechanism.
  • the method includes shortening the adjustable mechanism in resp onse to a stimuli and thereby resulting in a distance between the adjustable mechanism and the anchor object reducing such as to tighten tissue between the anchor object and the adjustable mechanism.
  • the adjustable mechanism includes a mechanism selected from the group of: piezoelectric, magnetic, screw-threads, spring, memory metal, elastic, mechanical mechanism, temperature sensitive material, and combinations thereof.
  • the stimulating is selected from a radio frequency, ultra-sound, mechanical force, pressure, direct mechanical manipulation, magnetic force, chemical interaction, enzyme interaction, fluid, temperature, biological fluid, cellular interaction, cellular by-product, inter-cellular constituent, intra-oellular constituent, food, digestion by-product, a lapse of time, and combinations thereof.
  • the present invention discloses a surgical tool support system that includes an anchor object configured and dimensioned to be attached to a body tissue and a manipulation line extending from the anchor object and configured and dimensioned to couple with a surgical tool.
  • the manipulation line is fabricated from one of the group of a suture, resorbable suture, stainless steel, surgical wire, braided wire, and combinations thereof.
  • the present invention also includes a method of manipulating a surgical tool including forming an incision in body tissue, attaching a manipulation line to body tissue near the incision, introducing a surgical device through the incision in the body tissue, attaching a free end of the manipulation line to the surgical device, and manipulating the surgical tool to perform a medical treatment procedure.
  • the manipulation line can provide a cantilever for the surgical tool.
  • the manipulation line at least partially supports the surgical device.
  • method includes implanting a plurality of manipulation lines between the body tissue and the surgical tool. The plurality of manipulation lines are evenly distributed around the surgical tool.
  • FIG. 1 shows a schematic view of an endo luminal surgical device according to an embodiment of th ⁇ present invention
  • FIG. 2 shoivs a schematic view of a tissue engaging end effecter of an endoluminal surgibal device according to an embodiment of the present invention
  • FIG. 3 shoivs an implanted device according to an embodiment of the present invention
  • FIG. 4 shows an device positioned on an end effecter prior to implantation according to an embodiment of the present invention
  • FIG. 5 shows a tissue plication including an implanted device according to an embodiment of the present invention
  • FIG. 5A shows an alternative embodiment of an implant device
  • FIG. 6 shows another device positioned on an end effecter prior to implantation according to an enubodiment of the present invention
  • FIG. 7 shows another tissue plication including an implanted device according to an embodiment ofjthe present invention.
  • FIG. 8 shojvs yet device positioned on an end effecter prior to implantation according to an enjibodiment of the present invention
  • FIG. 9 shoivs another tissue plication including an implanted device according to an embodiment ofjthe present invention.
  • FIG. 10 shj ws an end effecter with a tissue plication formed on a needle of the end effecter according to an embodiment of the present invention
  • FIG. 11 shows an end effecter with multiple tissue plications formed on a needle of the end effecter according to an embodiment of the present invention
  • -12C show embodiments of a tissue plication and corresponding open tissue pocket according to embodiments of the present invention
  • FIGS. 13Aj and 13B show implanted devices according to other embodiments of the present invention.
  • FIG. 14 shbws an implanted device according to another embodiment of the present invention.
  • FIGS. 15A and 15B show an adjustable implantable device according to an embodiment of th ⁇ present invention
  • FIG. 16 shpws a surgical device stabilization device according to an embodiment of the present invention.
  • FIG. 17 shbws a guide wire for guiding a tissue retractor according to an embodiment of the present invention.
  • An endoluminal device 100 such as that shown in FIG. 1 and disclosed in U.S. Patent No's. 6,835,200; 6,821,285; 6,773,441 ; 6,663,639; 6,506,196; and 6,494,888, and U.S. Published Application No's. 2005/0033328; 2004/0194790; 2004/0193194; 2004/0193193; 2004/0193184; 2004/0193117; 2002/0193816; and U.S. Provisional patent application no 60/741,510 filed December 1, 2005, the disclosure of each being hereby incorporated by reference in their entirety, is utilized in the present invention to manipulate tissue of a patient.
  • the endoluminal device 100 is configured such that it can be positioned within a hollow organ by entry through a body cavity opening, such as for exampje, positioning the device into the stomach via the mouth of a patient. Once situated, the pevice is capable of manipulating tissue and implanting objects or devices.
  • tissue of an organ such as for example, the stomach
  • a suture based implant can be implanted to maintain the manipulated character of the tissue.
  • a drug or device can also be introduced into the lumen of the organ and implanted or attached to the organ wall with a suture based implant.
  • the foldls can be positioned vertically with respect to each other and the suture based implants caji be drawn together such as to form an artificial biological tube.
  • endo luminal surgical device 100 is shown according to an embodiment of th£ present invention.
  • Endoluminal surgical device 100 further includes a generally longitudinal and flexible shaft 102 that includes an end effecter 200 (FIG. 2) configured near its distal end.
  • End effecter 200 includes first arm 202 and second arm 204.
  • First arm 202 and second arm 204 are configured to engage tissue and implant anchor object 220.
  • anchor object 220 generally includes pledgets 222 and 224 which, according to some embodiments, are connected by suture 226.
  • Endoluminal surgical device 100, end effecter 200, and anchor object 220 are further disclosed in the reference publications and applications that are incorporated herein by reference.
  • anchor object can be constructed from any biocompatible material, such as, but not limited to, stainless steel, cobalt chromium, titanium, alloys of such metals, biocompatible polymers, soluble polymers, non-soluble polymers, swellable polymers, absorbable polymers, suture material, bioresorbable suture, bioabsorbable suture, combinations thereof, or the like.
  • biocompatible material such as, but not limited to, stainless steel, cobalt chromium, titanium, alloys of such metals, biocompatible polymers, soluble polymers, non-soluble polymers, swellable polymers, absorbable polymers, suture material, bioresorbable suture, bioabsorbable suture, combinations thereof, or the like.
  • endoluminal surgical device 100 is utilized to manipulate tissue.
  • Tissue from the wall of a hollow organ, such as for example the stomach, is formed into plications, such as plication Pl.
  • Plication Pl is formed by gathering or manipulating tissue of the wall of the organ with end effecter 200 into a fold and piercing the folded tissue with needle 206 of end effecter 200.
  • Needle 206 includes suture 312 and a suture based implant or pledget 314 associated therewith. According to an embodiment, one end of suture 312 is attached to pledget 314 and the other end of suture 312 remains free and outside the patient.
  • both ends of suture 312 remain free and outside the patient's body, however, pledget 314 is attached to suture at a predetermined location.
  • Pledget 314 can be loosely attached or securely attached o suture 312 by a knot, a clip, integral with suture 312, combinations thereof, or the like;.
  • a second pledget 316 is positioned with respect to suture 312.
  • Second pledget 316 is preferable positioned with respect to suture 3112 outside the body, however, second pledget 316 can be positioned onto suture 12 insjde the hollow organ.
  • Second pledget 316 is then moved into the hollow organ to be manipulated, a second fold of tissue or plication P2 is formed with the endo luminal or endoscopic surgical device 100 and plication P2 is pierced with needle 206 of the endoscope 100.
  • plication P2 is pierced, suture 312 is pushed through plication P2, ther ⁇ y, bringing pledget 316 into position adjacent a side of plication P2.
  • suture 312 is tightened such that plication Pl and plication P 2 are drawn together.
  • pledget 314 and pledget 316 are positioned on opp :>sing sides of plication Pl and P2, respectively.
  • pledget 314 and pledget 316 are positioned on the same side of plication Pl and plication P2. After suture 312 is tightened such that plication Pl and plication P2 are approximated together, suture 312 is fixed.
  • suture 312 can be either lemovably fixed or irremovably fixed to hold plication Pl and plication P2 in position.
  • Suture 312 can be fixed with a knot, a suture clip, fused together, combinations thereof, or the like.
  • a predetermined pressure can be applied through the tightening of suture 312 such as to generate a predetermined treatment condition between the plications. According to some embodiments, this procedure is performed in the stomach of a patient.
  • plication Pl and plication P2 are formed approximately 2 cm from gastroesophageal (GE) junction 310. According to alternative embodiments, plication Pl and plication P2 are formed between 2 cm and 5 cm from GE junction 310. Where the stomach condition to be treated requires enhancement or replacement of the gastric valve, such plications are preferably located in cooperative relationship with the GE junction to form an artificial gastric valve.
  • GE gastroesophageal
  • pledgets 314 and 316 may or may not be used to form plica ions Pl and P2, respectively. It should be appreciated that depending on a condition to be treated, tissue type being treated, location of treatment, size or area to be treated, combinations thereof, and the like, pledgets 314 and 316 may not be necessary, thereby , using suture 312 to form plications Pl and P2 and tighten plications Pl and P2 together.
  • multiple pledgets can be implanted adjacent one another such ⁇ s to treat a large tissue disturbance, such as a large incision, re- incision, necrotic $ite, fistula, combinations thereof, or the like.
  • a patch 318 can be introduced with endoluminal device i 100 into the organ] to be treated. Patch 318 can be associated with a tissue engaging portion of the device and placed on the wall of the organ when the tissue engaging portions grasp the iwall to form the plication.
  • patch 318 may be coupled with a plication, such as plication P2, through the securing implant such as pledget 316.
  • patch 318 may be formed as a resilient, clip- like member having at least two arms that can be secured to a plication previously formed by manipulating the tissue with the endoluminal device 100. As shown, for example, in Fig. 3, piercing of the tissue is not required for securing such an embodiment.
  • patch 318 can be attached at a plurality of locations to the wall of the organ. Patch 318 can increase the integrity of the organ.
  • pat ⁇ h 318 includes therapeutic agents such as, for example, antibiotics, drugs, inhibiting agents, anti-inflammatory agents, combinations thereof, and the like.
  • the therapeutic agents can be coated on patch 318 or they can be dispersed throughout the material that forms patch 318. Patch 318 can also be fabricated from non-absorbable or bio-resorbable materials. Other treatment devices as described below also my be employed.
  • end effecter 200 is shown having first arm 402 and second arm 404.
  • First arm 402 and second arm 404 are configured to engage and manipulate tissue.
  • second arm 404 includes a tissue piercing needle 406.
  • implant device 410 includes suture 412 that is attached to implant 414.
  • implant 414 can be, but is not limited to, a drug delivery device, such as for example a delayed delivery material, delayed absorbable drug elbding material, selectively drug permeable material or membrane, time release delivery dt vice, combination thereof, or the like.
  • implant 414 can be, but is not limited to a stimulator device, such as for example, an electrical stimulation device, mechanical stimulation device 7 vibratory device, sound stimulation device, ultra-sound stimulation device, combinations thereof, or the like.
  • the stimulation device can be configured to stimulate a sense of a patient.
  • the sense stimulated by the stimulation device can be a sense of satiety ijn the patient such that the patient's desire for eating is subsided.
  • implant 414 can be, but is not limited to, a sensory device, such as foil example, a device to monitor pH, pressure, temperature, salinity, hydration, cellularj activity, protein levels, glucose levels, insulin levels, hormone levels, biological function, biological secretion, cellular uptake, cellular secretion, combinations thereof, and the like.
  • implant 414 can be, but is not limited to, a device to control biological activity, such as for example, inter or intra cellular pH, temperature, salinity, cellular function, cellular excretion, cellular uptake, glucose levels, insulin levels, combinations thereof, and the like.
  • suture 412 can be resorbable suture material or non-resorbable suture material.
  • first arm 402 and second arm 404 are positioned with respect to tissue that is to be manipulated.
  • the arms are manipulated by actuating a control on endoluminal surgical device 100.
  • first arm 402 and second arm 404 are actuated, they move toward each other and tissue positioned between the arms is engaged and pierced with needle 406.
  • needle 406 is coupled with suture 412, and suture 412 is attached to implant device 410.
  • suture 412 is pierced through the tissue and extends through the tissue with implant device 410 on one side of the pierced tissue and a free end of suture 412 on the other side of the pierced tissue.
  • suture 412 can be formed as a loop to be secured around a natural or formed anatomical feature, such as a plication, utilizing! first an ⁇ 3 second arms 402 and 404 without piercing the tissue.
  • implant device 500 is shown implanted with respect to tissue of a patient.
  • tissue such as stomach wall tissue 504 and stomach mucosa 502 are formed into a plication 520.
  • Plication 520 is affixed with an anchor object that includes pledgets 506 and 510.
  • pledgets 506 and 510 can be coupled together with a tee bar 508 and suture 512 and in other embodiments pledgets can be coupled together only with suture 512.
  • Implant 514 is attached to the anchor object.
  • implant 514 can b ⁇ integral with pledget 510, coupled with pledget 510, or removable coupled with pledget 514.
  • the coupling between pledget 510 and implant 514 can be degradable over a predetermined time such that implant 514 become detached from pledget 510.
  • implant 514 can be any of the implant devic ⁇ s, sensors, drugs, drug delivery devices, monitors, control devices, combinations thereof, and the like that are described herein and/or incorporated into this application by reference. For example, as shown in FIG. 5 A, implant 514 is incorporated directly into pledgbt 510.
  • end effecter 200 is shown having first arm 602 as
  • Implant 614 further includes an affixing portion 616 for engaging with needle 606 and coupling thereto to bind tissue therebetween.
  • implant 614 can be any of the implant devices described herein or incorporated herein by reference.
  • suture 612 and pledget 610 can be fabricated according to other embodiments described herein or incorporated herein by reference.
  • a plication 720 can be formed from a tissue wall or lining 704 that may or may not include a mucosa 702.
  • Plication 720 is formed from binding tissue 704 with an, anchor object that includes pledgets 706 and 710.
  • pledgets 706 and 710 can be coupled with suture 712 and tee bar 708.
  • implant 714 can be implanted with anchor object by coupling implant T 1 14 between tissue wall 704 or tissue mucosa 702 and pledget 706.
  • implant 814 can be implanted on a tet er such that implant 814 is relatively affixed to tissue but not rigidly affixed to any particular tissue.
  • end effecter 200 includes first arm 802, second arm 8 )4, and tissue retractor 806.
  • Second arm 804 includes tissue piercing needle 808 for pie ring tissue and implanting implant 814.
  • Needle 808 further includes suture 812 for affifdng tissue that is pierced by needed 808 into a plication.
  • Suture 812 can include pledget 810 for biasing against tissue. In some embodiments, suture 812 extends further beyond pledget 810 and couples with implant 814.
  • second suture 816 extends from pledget 810 and couples with implant 814.
  • implant 814 is implanted into a patient and affixed into a general location,] however, implant 814 is semi-free to move within patient to the extent of tether provided
  • FIG. 9 shows tethered implant 814 in an implantejd position with respect to a tissue plication 920.
  • plication 920 is formed by anchoring a plication of tissue with an anchor object that includejs implant 814 tethered thereto by second suture 816.
  • an end effecter 200 has a first arm 1002, a second arm 1004, and a tissue retractor 1014 and is used to form a tissue plication 1006, as described herein.
  • Plication 1006 is formed by grasping tissue with retractor 1014 and manipulating first arm 1002 andi second arm 1004 together such that needle 1008 pierces the tissue.
  • Suture 1012 is associated with needle 1008 such that suture 1012 is pierced through tissue with needle 1008. After piercing the tissue with needle 1008, the tissue is retained on needle 1008.
  • retractor 1014 is used a second time to grasp a second portion of tissue such that the tissue can be positioned with respect to first arm 1002, second arm 1004, and needle 1008 and be pierced with needle 1008 to form second plication 1102.
  • an open pocket 1104 is formed.
  • an implant 1106 is housed in open pocket 1104.
  • end effecter 200 can have multiple retractors 1014 such that the retractor does not have to be removed from the tissue after forming a first plication in order to form a second plication.
  • a first retractor 1014 can grasp tissue and form a first plication while a second retractor grasps other tissue and forms a second pupation.
  • the two plications can be anchored together such that an open pocket 1104 s formed therebetween.
  • tissue graspers are introduced into th surgical site percutaneously for grasping tissue and manipulating it into adjacent plica ions that form the tube or open pocket 1104.
  • the tissue graspers pull tissue around the shaft 102 of the surgical device and position the tissue for implantation of the anchor object.
  • an anchor object is implanted to fasten the plications around the shaft of the surgical device.
  • the end effecter 200 is straightened such ⁇ s to be axially aligned with shaft 102 and the shaft 102 and end effecter 200 are relmoved through the open pocket 1104 of the tissue plications, leaving behind open pock ⁇ t 1104, or as shown in FIGS. 12B and 12C artificial tissue tube 1250.
  • tissue 1220 that forms pocket 1104 between plications 1006 and 1102 may be tissue that requires treatment or can be used for locating a treatment.
  • implant 1106 positioned in pocket 1104 is configured to treat tissue 1220 or otherwise provide treatment to surrounding areas.
  • tissue 1220 can be removed following the double plication procedure described with respect to FIGS. 10- 12 A.
  • tissue 1220 may dissolve or resorb following the double plication procedure.
  • multiple double plication procedures such as the double plication procedure described with respect to FIGS. 10-12 can be performed on the same tissue, in the same organ, or the like.
  • axially aligned double plications 1240, 1242, 1244, and 1246 can be positioned adjacent to each other such that each open pocket 1104, formed between the plications 1006 and 1102, is generally aligned and forms an artificial biological tube 1250.
  • artificial biological tube 1250 is formed by drawing each double plication together.
  • each plication 1240, 1242, 1244, and/or 1246 can be drawn together using surgical glue, suture material, surgical wire, staples, scoring the tissue such that th ⁇ tissue reforms together, combinations thereof, or the like.
  • vertically aligned double plications 1240, 1242, and 1244 are positioned, beginning at or distally near the gastro-esophageal-j unction (GEJ) 1252 and extend into th ⁇ stomach, thereby forming an artificial GEJ or gastric tube 1250.
  • GEJ gastro-esophageal-j unction
  • the artificial gastric tube when the artificial gastric tube is flaccid, i.e., empty, the artificial gastric tube acts as a gastric flap or valve for protecting the esophagus from gastric fluids.
  • the formation of such an artificial gastric tube can be a treatment for gastro- esophageal reflux disorder (GERD).
  • the formation of an artificial gastric tube can be a technique for gastric reconstruction or reduction surgery. According to such embodiments, the formation of such an artificial gastric tube effectively reduces the volume of the stomach of a patient, and thereby, stimulates the stomach into providing a sense of satiety with consumption of a smaller amount of food.
  • between 1 and about 10 plications are positioned adjacent each other to form artificial t ⁇ be 1250. In other embodiments, between 1 and about 8 plications are positioned adjacent each other to form artificial tube 1250. In yet other embodiments, between 1 and about 5 plications are positioned adjacent each other to form artificial tube 1250.
  • between 1 and about 3 plications are positioned adjacent each othejr to form artificial tube 1250.
  • a single plication is positioned adjacent the GEJ to form artificial tube 1250 or GERD treatment.
  • between about 5 and about 8 plications are positioned adjacent each othelr to form artificial tube 1250.
  • artificial tube 125(1) is formed with between one and two tissue plications
  • artificial tube 1250 is about 1 cm in length.
  • artificial tube 1250 includes between about 10 to about 20 tissue plications
  • artificial tube 1250 is about 10 cm in length.
  • the diameter of artificial tube 1250 is between about 0.2 cm and about 10 cm.
  • the diameter of artificial tube 1250 is between about 0.5 cm and about 5 cm. In some embodiments, the diameter of artificial tube 1250 is between about 0.5 cm and about 3 cm. In some embodiments, the diameter of artificial tube 1250 is between about 0.5 cm and about 2 cm.
  • an implant device 1306 can be implanted onto tissue 1302 with multiple attachments, as shown in FIGS. 13A and 13B.
  • an implant 1306 can be located or held in position by coupling retractors 1304 A - 1304D to tissue 1302 and/or implant device 1306.
  • implant 1306 may be such a shape or dimension that multiple anchor implants are required for proper or secure attachment of implant 1306 to tissue 1302.
  • multiple anchors 1308A - 1308D are implanted throu gh tissue 1302 and implant 1306 to affix implant 1306 as desired to tissue 1302.
  • anchors 1308A - 1308D include pledgets 1310 and suture 1$12.
  • pledgets 1310 and suture 1312 can be fabricated i
  • anchor implant 1400 includes a coupling 1402 and pledgets 506 and 510 coupled together by suture 512.
  • Anchor implant 1400 is configured to couple tissue 5 ⁇
  • coujpling 1402 is configured to provide a site on anchor implant 1400 for attaching an implantable device, mechanical tool, drug eluding device, sensor, other device described or incorporated herein, combinations thereof, or the like.
  • coupling 1402 can be, but is not limited to a hook, clip, Velcro, magnet, loop, combinations thereof, or the like.
  • coupling 1402 can be formed from a non-resorbable polymer, resorbable polymer, biodegradable polymer, drug eluding polymer, stainless steel, titanium, cobalt chromium, surgical material, combinations thereof, or the like.
  • endoluminal surgical device 100 includes guide wire 1702 that includes tissue engaging retractor tip 1704.
  • tissue engaging retractor tip 1704 is configured to releasable attach to tissue at a site near where an implant attachment site is targeted.
  • tissue engaging retractor tip 1704 can be, but is not limited to a corkscrew type design, screw threads, a hook, a loop, jaws, locking jaws, combinations thereof, and the like.
  • having a guide wire 1702 that can attach to tissue or target a tissue at or near an implant site can help direct where the implant device will pass and increases the efficiency and effectiveness of surgical procedures because the path that the device is require to pass is less rigorous and/or straighter.
  • adjustable implantable device 1500 includes anchor implants 1506 and! 1508, however, the number of anchor implants used in practice can vary to what is ne ⁇ essary for a particular procedure being performed, corrected, or desired.
  • anchor implants include pledgets 1510 connected by suture 1512.
  • anchor implant 1506 is coupled with adjustment mechanism 1514 lj>y suture 1516 and anchor implant 1508 is coupled with adjustment mechanism 1514 by suture 1518.
  • Adjustment mechanism 1514 is configured to adjust a physical parameter, such as for example, length, width, diameter, rotational axis, combinations ther ⁇ of, or the like, in response to stimulation.
  • adjustment mechanism 1514 linearly shortens in response to a predetermined stimulation.
  • a predetermined stimulation can be, but is not limited to, a radio frequency, ultra-sc und, mechanical force, pressure, direct mechanical manipulation, magnetic force, ch emical interaction, enzyme interaction, fluid, temperature, biological fluid, cellular interaction, cellular by-product, inter-cellular constituent, intra-cellular constituent, food, digestion by-product, time, combinations thereof, or the like.
  • adjustable implant device 1500 is implanted into the tissue surrounding the gastro-esophageal-junction (GEJ). Having the adjustable implant device 1500 implanted in or near the GEJ allows the adjustable implant device 1500 to assist or augment the natural function of the GEJ.
  • GEJ gastro-esophageal-junction
  • adjustable implant device 1500 leaves the GEJ in an open state such that food, liquids, or the like can be passed from the esophagus into the stomach of a patient.
  • adjustable mechanism 1514 shortens and, thereby, tightens the GEJ such that gastric fluids are blocked from passing from the stomach into the esophagus and causing or worsening a patient's GERD condition.
  • adjustable mechanism 1514 ⁇ an be a threaded mechanism, a coil mechanism, a spring mechanism, a magnetic mechanism, a ratchet mechanism, memory material, piezoelectric material, temperature sensitive material, combinations thereof, or the like.
  • adjustable implant device 1500 can be implanted in a stomach of a patjent. Implanting adjustable implant device 1500 into a stomach allows a patient or physician to reversibly and/or temporarily restrict the volume of the stomach of a patient in respjonse to a predetermined stimulus. According to some embodiments adjustable implant! device 1500, when implanted in the stomach of a patient, can be retracted or adjusted prior to consuming food and thereby act as a temporary gastric restriction device. In some embodiments, adjustable implant device 1500 can be configured to respond to a digestive by-product, a cellular excretion, particular gastric fluids, an external stimulation, combinations thereof, or the like.
  • adjustable iir ⁇ lant device 1500 can be implanted in many locations in a patient, such as but not limited to, any sphincter, tubular organ such as the intestine, muscle, skeletal system, combinatipns thereof, or the like.
  • a surgical stabilization system is shown.
  • a surgical device needs to be inserted through tissue, a tissue wall such as an abdominal wall, an organ wall such as the stomach, or the like.
  • tissue wall such as an abdominal wall, an organ wall such as the stomach, or the like.
  • a surgeon loses much control over a working end of a surgical instrument after the instrument has been passed through the tissue wall.
  • mo ⁇ e or less stabilizers can be utilized depending the requirements of particular situation. For simplicity sake only one stabilizer will be described, however, it will be appreciated that each stabilizer includes generally the same construction.
  • a stabilizer such as stabilizer 1406 for example, includes a tissue anchor end and a device anchor end.
  • the tissue anchor end includes pledgets 1416 and 1417 connected by suture material 1418.
  • Pledgets 1416 and 1417 and suture material 1418 can be implanted according to methods and with devices disclosed herein or incorporated herein by reference.
  • Pledget 1417 is further connected to line 1420 that extends from pledget 1417 to device 102.
  • Line 1420 can be, but is not limited to, suture material, wire, rods, k-wires, t-bars, or other surgical material or devices that can support tension, pressure, and/or torque.
  • the device anchoring end of stabilization 1418 can be configured to couple to an attachment on device 102 such that a force applied to stabilizer 1418 can be translated to device 102 and/or manipulation force applied to device 102 can be leveraged over and around stabilization 1418.
  • stabilization devices can be implanted as desired to assist in manipulating surgical device 102.

Abstract

An endoluminal treatment device and method includes introducing an endoluminal device into a lume|n of a patient and engaging a wall of the lumen with an implant device. The implant devicje can be a drug delivery device or medical device.

Description

DEVICES AND METHODS FOR ENDOLUMINAL GASTRIC RESTRICTION, TISSUE MANIPULATION, AND DRUG DELIVERY
CROSS-REFERENCE TO RELATED APPLICATION [001 ] This application claims the benefit of Provisional Patent Application No. 60/849,414, filed ^ctober 4, 2006, which is incorporated by reference herein in its entirety.
TECHNICAL FIELD OF THE INVENTION
[002] Generally, J the present invention is related to endoluminal surgical devices, methods, device, a|nd drug delivery. More particularly, the devices and methods provide for endoluminal gastric restriction, endoluminal gastric tissue reconfiguration, endoluminal drug delivery, endoluminal device delivery, and the like.
BACKGROUND OF THE FIELD OF THE INVENTION
[003] Laparoscopic surgery has greatly reduced the size and scope of incisions made in a patient and resulted in reduced morbidity and mortality rates. However, even with the reductions in the size and scope of incisions as a result of laparoscopic surgery, complications in amd during surgical procedures remain. A technique that is developing to further reduce surgical complications is to work through an endoluminal access port. One endoluminal access port is the mouth and this access port can give a surgeon access to a patient's esophagus and stomach.
[004] Stomach tigsue often needs surgical treatment to treat fistulas and to close transgastric incisic ns to stop stomach fluids from leaking from the stomach to surrounding tissue and to stop infectious matter from spreading from or to the stomach tissue. Other ston ach treatments include stomach reduction procedures for obese patients. Traditionally, physicians have been placing devices such as the Lap Band® on the external surface of the gastric wall to create a restricted stomach capacity. Another traditional procedure for stomach reduction includes a laparoscopic procedure in which surgeons protrude into the stomach from the exterior of the patient and staple the stomach into a smaller volume. This restriction creates a pouch inside the stomach which fills quickly when food is ingested and assists in generating a sensation of being full. However, these procedures have drawbacks such as complications from port punctures of the stomach, large- incisions, substantial recovery time, expense, lost productive work time, infection, and the like.
[005] However, the incision required by the current surgical procedures include a morbidity and mortality rate that can be reduced by reducing or eliminating the need for an incision by approaching the surgical site through endoluminal procedures.
SUMMARY OF THE INVENTION
[006] According to an embodiment, the present invention includes an implant device including a medical implant configured to be implanted into a lumen of a body without creating an incision in the body, wherein the medical implant is configured to maintain a plication in a wall of the lumen and wherein the medical implant includes a medical treatment. The mfdical treatment can include a drug delivery, a time released drug delivery, a coating, a biological stimulation device, a monitoring device, a feeding tube, a bioresorbable material, and combinations thereof. The biological stimulation device can be selected from the group consisting of an electrical stimulation device, mechanical stimulation device;, vibratory device, sound device, ultra-sound device, chemical stimulatory device, neurotransmitter stimulation device, thermal stimulation, sensory stimulatory device, and combinations thereof.
[007] In some embodiments, the implant device further includes a controller configured to control the biological stimulation device. The controller can control the biological stimulation device from external to the body and through radio frequency. The monitoring device can be selected from the group of a pH sensor, pressure sensor, video sensor, chemical sensor, hormone sensor, dilation sensor, fluid sensor, ion sensor, tissue extension sensor, and combinations thereof. In some embodiments, the medical treatment includes material selected from radioactive material, chemotherapy material, biological materia , and combinations thereof. [008] In some embodiments, the medical treatment is configured to treat a gastric condition. In some embodiments, the medical implant is includes bioresorbable material including a drug.
[009] In alternative embodiments, an endoscopic treatment method includes introducing an endoscopic device into a lumen of a patient without creating an incision in the patient, engaging a wall of the lumen with an end effecter of the endoscopic device to form a plication, and activating the end effecter to secure the plication with an anchor object and a treatment device, wherein the treatment device is coupled with the anchor object.
[0010] In some embodiments, an endoscopic treatment method includes introducing an endoscopic device into a lumen of a patient without creating an incision in the patient, introducing a treatment device into the lumen, engaging a wall of the lumen with an end effecter of the endoscopic device, forming a first plication in the wall of the lumen, forming a second plication in the wall of the lumen adjacent the first plication, and coupling the first plication with the second plication to thereby form a first double plication wherein an open pocket is formed between the first plication and the second plication. In alternative embodiments, the method includes forming a second double plication adjacent the first double plication, wherein a second open pocket formed by the second double pliqation and the open pocked formed by the first double plication are axially aligned. IrI other embodiments, the method includes forming an artificial biological tube bylaligning multiple double plications such that open pockets formed by the multiple double plications axially align. In some embodiments, the method includes coupling the first double plication with the second double plication.
[0011] According to yet other embodiments, an endoscopic GERD treatment method includes introducing an endoscopic device into a lumen of a patient without creating an incision in the patient, engaging a wall of the lumen with an end effecter of the endoscopic device^ and forming a plication in the wall of the lumen near the gastroesophageal -junction such that an artificial biologic tube is formed distal to the gastroesophageal -juncticjn to block gastric fluid from interfering with tissue of the esophagus. In some embodiments, the method includes forming a plurality of plications extending distally from the gbstro-esophageal-junction. In some embodiments, the artificial biologic tube is be|tween about 0.5 cm and about 5 cm in length. In alternative embodiments, the Artificial biologic tube is between about 0.5 cm and about 3 cm in diameter. In furtrφr embodiments, the plurality of plications is coupled together with glue, suture, wire, jor tissue re-growth after stimulation. ϊ
[0012] In other embodiments, an endoscopic obesity treatment method includes introducing an endoscopic device into a stomach of a patient without creating an incision in the patient, engaging a wall of the stomach with an end effecter of the endoscopic device, and forming a plication in the wall of the stomach such that an artificial biologic tube is formed wiψin the stomach of the patient and thereby reducing a volume of the stomach to treat obesity.
[0013] In alternative embodiments, a medical implant apparatus includes an anchor object configured ;o couple with tissue and an adjustable mechanism configured to interact with the anchor object such as to apply alternative forces upon the anchor object in response to a stimulus. In some embodiments, the adjustable mechanism is coupled with the anchor object through suture material. In other embodiments, the adjustable mechanism is coupled with the anchor object through surgical wire. In some embodiments, the adjustable mechanism shortens in response to a stimuli. In some embodiments, the adjustable mechanism includes a mechanism selected from the group consisting of: piezoelectric, magnetic, screw-threads, spring, memory metal, elastic, mechanical mechanism, temperature sensitive material, and combinations thereof. According to some embodiments, the stimuli is selected from the group of a radio frequency, ultra-sound, mechanical force, pressure, direct mechanical manipulation, magnetic force, chemical interaction, enzyme interaction, fluid, temperature, biological fluid, cellular interaction, cellular by-product, inter-cellular constituent, intra-cellular constituent, food, digestion by-product, a lapse of time, and combinations thereof. In some embodiments, the device further includes a plurality of anchor objects wherein each anchor object is ccupled with the adjustable mechanism such that an adjustable substantially sphincter shaped tissue structure is formed.
[0014] According o some embodiments, a method for temporary tissue restructuring includes implanting an anchor object onto tissue to be adjustably restructured, associating an adjustable mechanism with the anchor object such that a force generated by the adjustable mechanjism can change a relative position of the anchor object with respect to the adjustable medhanism and thereby restructures tissue, and stimulating the adjustable mechanism to generate the force. In some embodiments, the method further includes a plurality of anchor objects, wherein each anchor object is coupled with the adjustable mechanism. The plurality of anchor objects can be coupled in series with the adjustable mechanism. In sofne embodiments, the method includes shortening the adjustable mechanism in resp onse to a stimuli and thereby resulting in a distance between the adjustable mechanism and the anchor object reducing such as to tighten tissue between the anchor object and the adjustable mechanism. In other embodiments, the adjustable mechanism includes a mechanism selected from the group of: piezoelectric, magnetic, screw-threads, spring, memory metal, elastic, mechanical mechanism, temperature sensitive material, and combinations thereof. In some embodiments, the stimulating is selected from a radio frequency, ultra-sound, mechanical force, pressure, direct mechanical manipulation, magnetic force, chemical interaction, enzyme interaction, fluid, temperature, biological fluid, cellular interaction, cellular by-product, inter-cellular constituent, intra-oellular constituent, food, digestion by-product, a lapse of time, and combinations thereof.
[0015] According to alternative embodiments, the present invention discloses a surgical tool support system that includes an anchor object configured and dimensioned to be attached to a body tissue and a manipulation line extending from the anchor object and configured and dimensioned to couple with a surgical tool. In some embodiments, the manipulation line is fabricated from one of the group of a suture, resorbable suture, stainless steel, surgical wire, braided wire, and combinations thereof.
[0016] In alternative embodiments, the present invention also includes a method of manipulating a surgical tool including forming an incision in body tissue, attaching a manipulation line to body tissue near the incision, introducing a surgical device through the incision in the body tissue, attaching a free end of the manipulation line to the surgical device, and manipulating the surgical tool to perform a medical treatment procedure. The manipulation line can provide a cantilever for the surgical tool. The manipulation line at least partially supports the surgical device. In some embodiments, method includes implanting a plurality of manipulation lines between the body tissue and the surgical tool. The plurality of manipulation lines are evenly distributed around the surgical tool.
BRIEF DESCRIPTION OF THE FIGURES
[0017] FIG. 1 shows a schematic view of an endo luminal surgical device according to an embodiment of th^ present invention;
[0018] FIG. 2 shoivs a schematic view of a tissue engaging end effecter of an endoluminal surgibal device according to an embodiment of the present invention;
[0019] FIG. 3 shoivs an implanted device according to an embodiment of the present invention;
[0020] FIG. 4 shows an device positioned on an end effecter prior to implantation according to an embodiment of the present invention;
[0021] FIG. 5 shows a tissue plication including an implanted device according to an embodiment of the present invention;
[0022] FIG. 5A shows an alternative embodiment of an implant device;
[0023] FIG. 6 shows another device positioned on an end effecter prior to implantation according to an enubodiment of the present invention;
[0024] FIG. 7 shows another tissue plication including an implanted device according to an embodiment ofjthe present invention;
[0025] FIG. 8 shojvs yet device positioned on an end effecter prior to implantation according to an enjibodiment of the present invention;
[0026] FIG. 9 shoivs another tissue plication including an implanted device according to an embodiment ofjthe present invention;
[0027] FIG. 10 shj)ws an end effecter with a tissue plication formed on a needle of the end effecter according to an embodiment of the present invention;
[0028] FIG. 11 shows an end effecter with multiple tissue plications formed on a needle of the end effecter according to an embodiment of the present invention; [0029] FIGS. 12A|-12C show embodiments of a tissue plication and corresponding open tissue pocket according to embodiments of the present invention;
[0030] FIGS. 13Aj and 13B show implanted devices according to other embodiments of the present invention;
[0031] FIG. 14 shbws an implanted device according to another embodiment of the present invention;
[0032] FIGS. 15A and 15B show an adjustable implantable device according to an embodiment of thφ present invention;
[0033] FIG. 16 shpws a surgical device stabilization device according to an embodiment of the present invention; and
[0034] FIG. 17 shbws a guide wire for guiding a tissue retractor according to an embodiment of the present invention.
DETAILEt) DESCRIPTION OF EMBODIMENTS OF THE INVENTION
[0035] An endoluminal device 100, such as that shown in FIG. 1 and disclosed in U.S. Patent No's. 6,835,200; 6,821,285; 6,773,441 ; 6,663,639; 6,506,196; and 6,494,888, and U.S. Published Application No's. 2005/0033328; 2004/0194790; 2004/0193194; 2004/0193193; 2004/0193184; 2004/0193117; 2002/0193816; and U.S. Provisional patent application no 60/741,510 filed December 1, 2005, the disclosure of each being hereby incorporated by reference in their entirety, is utilized in the present invention to manipulate tissue of a patient. Generally, the endoluminal device 100 is configured such that it can be positioned within a hollow organ by entry through a body cavity opening, such as for exampje, positioning the device into the stomach via the mouth of a patient. Once situated, the pevice is capable of manipulating tissue and implanting objects or devices.
[0036] According to some embodiments of the present invention, methods and devices are provided for delivering devices or drugs into the lumen of an organ, manipulate tissue, close incisi< ns, repair fistulas, and the like by an endoluminal approach. The tissue of an organ, such as for example, the stomach, can be manipulated to generate a fold, plication, or 1 ube and a suture based implant can be implanted to maintain the manipulated character of the tissue. In some embodiments, a drug or device can also be introduced into the lumen of the organ and implanted or attached to the organ wall with a suture based implant. In some embodiments, after the tissue is manipulated into folds or plications the foldls can be positioned vertically with respect to each other and the suture based implants caji be drawn together such as to form an artificial biological tube.
[0037] Referring ^o FIG. 1, endo luminal surgical device 100 is shown according to an embodiment of th£ present invention. Endoluminal surgical device 100 further includes a generally longitudinal and flexible shaft 102 that includes an end effecter 200 (FIG. 2) configured near its distal end. End effecter 200 includes first arm 202 and second arm 204. First arm 202 and second arm 204 are configured to engage tissue and implant anchor object 220. According to some embodiments, anchor object 220 generally includes pledgets 222 and 224 which, according to some embodiments, are connected by suture 226. Endoluminal surgical device 100, end effecter 200, and anchor object 220 are further disclosed in the reference publications and applications that are incorporated herein by reference. As described in further detail in the publications and applications incorporated herein by reference, anchor object can be constructed from any biocompatible material, such as, but not limited to, stainless steel, cobalt chromium, titanium, alloys of such metals, biocompatible polymers, soluble polymers, non-soluble polymers, swellable polymers, absorbable polymers, suture material, bioresorbable suture, bioabsorbable suture, combinations thereof, or the like.
[0038] Referring now to FIG.3, endoluminal surgical device 100 is utilized to manipulate tissue. Tissue from the wall of a hollow organ, such as for example the stomach, is formed into plications, such as plication Pl. Plication Pl is formed by gathering or manipulating tissue of the wall of the organ with end effecter 200 into a fold and piercing the folded tissue with needle 206 of end effecter 200. Needle 206 includes suture 312 and a suture based implant or pledget 314 associated therewith. According to an embodiment, one end of suture 312 is attached to pledget 314 and the other end of suture 312 remains free and outside the patient. According to an alternative embodiment, both ends of suture 312 remain free and outside the patient's body, however, pledget 314 is attached to suture at a predetermined location. Pledget 314 can be loosely attached or securely attached o suture 312 by a knot, a clip, integral with suture 312, combinations thereof, or the like;. Following implantation of pledget 314, a second pledget 316 is positioned with respect to suture 312. Second pledget 316 is preferable positioned with respect to suture 3112 outside the body, however, second pledget 316 can be positioned onto suture 12 insjde the hollow organ. Second pledget 316 is then moved into the hollow organ to be manipulated, a second fold of tissue or plication P2 is formed with the endo luminal or endoscopic surgical device 100 and plication P2 is pierced with needle 206 of the endoscope 100. When plication P2 is pierced, suture 312 is pushed through plication P2, therφy, bringing pledget 316 into position adjacent a side of plication P2. Following positioning of pledgets 314 and 316, suture 312 is tightened such that plication Pl and plication P 2 are drawn together. Preferably, pledget 314 and pledget 316 are positioned on opp :>sing sides of plication Pl and P2, respectively. In an alternative embodiment, pledget 314 and pledget 316 are positioned on the same side of plication Pl and plication P2. After suture 312 is tightened such that plication Pl and plication P2 are approximated together, suture 312 is fixed. According to alternative embodiments, suture 312 can be either lemovably fixed or irremovably fixed to hold plication Pl and plication P2 in position. Suture 312 can be fixed with a knot, a suture clip, fused together, combinations thereof, or the like. Furthermore, a predetermined pressure can be applied through the tightening of suture 312 such as to generate a predetermined treatment condition between the plications. According to some embodiments, this procedure is performed in the stomach of a patient. According to one embodiment of treating a stomach condition, plication Pl and plication P2 are formed approximately 2 cm from gastroesophageal (GE) junction 310. According to alternative embodiments, plication Pl and plication P2 are formed between 2 cm and 5 cm from GE junction 310. Where the stomach condition to be treated requires enhancement or replacement of the gastric valve, such plications are preferably located in cooperative relationship with the GE junction to form an artificial gastric valve.
[0039] According to alternative embodiments, pledgets 314 and 316 may or may not be used to form plica ions Pl and P2, respectively. It should be appreciated that depending on a condition to be treated, tissue type being treated, location of treatment, size or area to be treated, combinations thereof, and the like, pledgets 314 and 316 may not be necessary, thereby , using suture 312 to form plications Pl and P2 and tighten plications Pl and P2 together. In some embodiments, multiple pledgets can be implanted adjacent one another such ^s to treat a large tissue disturbance, such as a large incision, re- incision, necrotic $ite, fistula, combinations thereof, or the like.
[0040] In some embodiments, a patch 318 can be introduced with endoluminal device i 100 into the organ] to be treated. Patch 318 can be associated with a tissue engaging portion of the device and placed on the wall of the organ when the tissue engaging portions grasp the iwall to form the plication. In some embodiments, patch 318 may be coupled with a plication, such as plication P2, through the securing implant such as pledget 316. In one exemplary embodiment, patch 318 may be formed as a resilient, clip- like member having at least two arms that can be secured to a plication previously formed by manipulating the tissue with the endoluminal device 100. As shown, for example, in Fig. 3, piercing of the tissue is not required for securing such an embodiment. According to alternative embodiments, patch 318 can be attached at a plurality of locations to the wall of the organ. Patch 318 can increase the integrity of the organ. In some embodiments, patφh 318 includes therapeutic agents such as, for example, antibiotics, drugs, inhibiting agents, anti-inflammatory agents, combinations thereof, and the like. The therapeutic agents can be coated on patch 318 or they can be dispersed throughout the material that forms patch 318. Patch 318 can also be fabricated from non-absorbable or bio-resorbable materials. Other treatment devices as described below also my be employed.
[0041] Referring mow to FIG. 4, end effecter 200 is shown having first arm 402 and second arm 404. First arm 402 and second arm 404 are configured to engage and manipulate tissue. In some embodiments, second arm 404 includes a tissue piercing needle 406. In some embodiments, implant device 410 includes suture 412 that is attached to implant 414. In some embodiments implant 414 can be, but is not limited to, a drug delivery device, such as for example a delayed delivery material, delayed absorbable drug elbding material, selectively drug permeable material or membrane, time release delivery dt vice, combination thereof, or the like. In alternative embodiments, implant 414 can be, but is not limited to a stimulator device, such as for example, an electrical stimulation device, mechanical stimulation device7 vibratory device, sound stimulation device, ultra-sound stimulation device, combinations thereof, or the like. In some embodiments, the stimulation device can be configured to stimulate a sense of a patient. In a preferred embodiment, the sense stimulated by the stimulation device can be a sense of satiety ijn the patient such that the patient's desire for eating is subsided. In further alternative (embodiments, implant 414 can be, but is not limited to, a sensory device, such as foil example, a device to monitor pH, pressure, temperature, salinity, hydration, cellularj activity, protein levels, glucose levels, insulin levels, hormone levels, biological function, biological secretion, cellular uptake, cellular secretion, combinations thereof, and the like. In further embodiments, implant 414 can be, but is not limited to, a device to control biological activity, such as for example, inter or intra cellular pH, temperature, salinity, cellular function, cellular excretion, cellular uptake, glucose levels, insulin levels, combinations thereof, and the like. In alternative embodiments, suture 412 can be resorbable suture material or non-resorbable suture material.
[0042] In some embodiments, first arm 402 and second arm 404 are positioned with respect to tissue that is to be manipulated. The arms are manipulated by actuating a control on endoluminal surgical device 100. When first arm 402 and second arm 404 are actuated, they move toward each other and tissue positioned between the arms is engaged and pierced with needle 406. In some embodiments, needle 406 is coupled with suture 412, and suture 412 is attached to implant device 410. Following activation of the arms and piercing tissud with needle 406, suture 412 is pierced through the tissue and extends through the tissue with implant device 410 on one side of the pierced tissue and a free end of suture 412 on the other side of the pierced tissue. Alternatively, suture 412 can be formed as a loop to be secured around a natural or formed anatomical feature, such as a plication, utilizing! first an<3 second arms 402 and 404 without piercing the tissue.
[0043] According !to FIG. 5, implant device 500 is shown implanted with respect to tissue of a patient. According to an embodiment, tissue, such as stomach wall tissue 504 and stomach mucosa 502 are formed into a plication 520. Plication 520 is affixed with an anchor object that includes pledgets 506 and 510. In some embodiments, pledgets 506 and 510 can be coupled together with a tee bar 508 and suture 512 and in other embodiments pledgets can be coupled together only with suture 512. Implant 514 is attached to the anchor object. According to some embodiments, as shown in FIG 5, implant 514 can bφ integral with pledget 510, coupled with pledget 510, or removable coupled with pledget 514. In some embodiments, the coupling between pledget 510 and implant 514 can be degradable over a predetermined time such that implant 514 become detached from pledget 510. According to other embodiments, implant 514 can be any of the implant devicøs, sensors, drugs, drug delivery devices, monitors, control devices, combinations thereof, and the like that are described herein and/or incorporated into this application by reference. For example, as shown in FIG. 5 A, implant 514 is incorporated directly into pledgbt 510.
[0044] Referring ώow to FIG. 6, end effecter 200 is shown having first arm 602 as
Figure imgf000013_0001
couple with implaht 614. Implant 614 further includes an affixing portion 616 for engaging with needle 606 and coupling thereto to bind tissue therebetween. In some embodiments, implant 614 can be any of the implant devices described herein or incorporated herein by reference. In other embodiments, suture 612 and pledget 610 can be fabricated according to other embodiments described herein or incorporated herein by reference.
[0045] According to FIG. 7, a plication 720 can be formed from a tissue wall or lining 704 that may or may not include a mucosa 702. Plication 720 is formed from binding tissue 704 with an, anchor object that includes pledgets 706 and 710. In some embodiments, pledgets 706 and 710 can be coupled with suture 712 and tee bar 708. According to somέ embodiments, implant 714 can be implanted with anchor object by coupling implant T114 between tissue wall 704 or tissue mucosa 702 and pledget 706.
[0046] According to other embodiments, as shown in FIG. 8, implant 814 can be implanted on a tet er such that implant 814 is relatively affixed to tissue but not rigidly affixed to any particular tissue. According to FIG. 8, end effecter 200 includes first arm 802, second arm 8 )4, and tissue retractor 806. Second arm 804 includes tissue piercing needle 808 for pie ring tissue and implanting implant 814. Needle 808 further includes suture 812 for affifdng tissue that is pierced by needed 808 into a plication. Suture 812 can include pledget 810 for biasing against tissue. In some embodiments, suture 812 extends further beyond pledget 810 and couples with implant 814. In other embodiments, second suture 816 extends from pledget 810 and couples with implant 814. According to suchj embodiments, implant 814 is implanted into a patient and affixed into a general location,] however, implant 814 is semi-free to move within patient to the extent of tether provided |between pledget 810 and implant 814. FIG. 9 shows tethered implant 814 in an implantejd position with respect to a tissue plication 920. According to some embodiments, plication 920 is formed by anchoring a plication of tissue with an anchor object that includejs implant 814 tethered thereto by second suture 816.
[0047] Referring now to FIGS. 10-12C, a plication that forms an open pocket or biologic tube is shown. In FIG. 10, an end effecter 200 has a first arm 1002, a second arm 1004, and a tissue retractor 1014 and is used to form a tissue plication 1006, as described herein. Plication 1006 is formed by grasping tissue with retractor 1014 and manipulating first arm 1002 andi second arm 1004 together such that needle 1008 pierces the tissue. Suture 1012 is associated with needle 1008 such that suture 1012 is pierced through tissue with needle 1008. After piercing the tissue with needle 1008, the tissue is retained on needle 1008. Referring now to FIG. 11, retractor 1014 is used a second time to grasp a second portion of tissue such that the tissue can be positioned with respect to first arm 1002, second arm 1004, and needle 1008 and be pierced with needle 1008 to form second plication 1102. By forming two adjacent plications 1006 and 1102, an open pocket 1104 is formed. In some embodiments, an implant 1106 is housed in open pocket 1104.
[0048] In some embodiments, end effecter 200 can have multiple retractors 1014 such that the retractor does not have to be removed from the tissue after forming a first plication in order to form a second plication. In other words, a first retractor 1014 can grasp tissue and form a first plication while a second retractor grasps other tissue and forms a second pupation. Next, the two plications can be anchored together such that an open pocket 1104 s formed therebetween. In yet other embodiments, tissue graspers are introduced into th surgical site percutaneously for grasping tissue and manipulating it into adjacent plica ions that form the tube or open pocket 1104. In some embodiments, the tissue graspers pull tissue around the shaft 102 of the surgical device and position the tissue for implantation of the anchor object. Next, an anchor object is implanted to fasten the plications around the shaft of the surgical device. After the desired number of plications are fixed around the shaft of the surgical device, the end effecter 200 is straightened such ^s to be axially aligned with shaft 102 and the shaft 102 and end effecter 200 are relmoved through the open pocket 1104 of the tissue plications, leaving behind open pockφt 1104, or as shown in FIGS. 12B and 12C artificial tissue tube 1250.
[0049] According to some embodiments, as shown in FIG. 12 A, tissue 1220 that forms pocket 1104 between plications 1006 and 1102 may be tissue that requires treatment or can be used for locating a treatment. According to such embodiments, implant 1106 positioned in pocket 1104 is configured to treat tissue 1220 or otherwise provide treatment to surrounding areas. In other embodiments, tissue 1220 can be removed following the double plication procedure described with respect to FIGS. 10- 12 A. In other embodiments, tissue 1220 may dissolve or resorb following the double plication procedure.
[0050] In other embodiments, multiple double plication procedures, such as the double plication procedure described with respect to FIGS. 10-12 can be performed on the same tissue, in the same organ, or the like. In some embodiments, as shown in FIGS. 12B-12C axially aligned double plications 1240, 1242, 1244, and 1246 can be positioned adjacent to each other such that each open pocket 1104, formed between the plications 1006 and 1102, is generally aligned and forms an artificial biological tube 1250. In some embodiments, artificial biological tube 1250 is formed by drawing each double plication together. In some jembodiments, each plication 1240, 1242, 1244, and/or 1246 can be drawn together using surgical glue, suture material, surgical wire, staples, scoring the tissue such that th^ tissue reforms together, combinations thereof, or the like.
[0051] In some enjibodiments, vertically aligned double plications 1240, 1242, and 1244 are positioned, beginning at or distally near the gastro-esophageal-j unction (GEJ) 1252 and extend into thφ stomach, thereby forming an artificial GEJ or gastric tube 1250. In some embodiments, when the artificial gastric tube is flaccid, i.e., empty, the artificial gastric tube acts as a gastric flap or valve for protecting the esophagus from gastric fluids. Thus, the formation of such an artificial gastric tube can be a treatment for gastro- esophageal reflux disorder (GERD). In other embodiments, the formation of an artificial gastric tube can be a technique for gastric reconstruction or reduction surgery. According to such embodiments, the formation of such an artificial gastric tube effectively reduces the volume of the stomach of a patient, and thereby, stimulates the stomach into providing a sense of satiety with consumption of a smaller amount of food. According to some embodimentjs, between 1 and about 10 plications are positioned adjacent each other to form artificial tψbe 1250. In other embodiments, between 1 and about 8 plications are positioned adjacent each other to form artificial tube 1250. In yet other embodiments, between 1 and about 5 plications are positioned adjacent each other to form artificial tube 1250. In yet otherj embodiments, between 1 and about 3 plications are positioned adjacent each othejr to form artificial tube 1250. In still other embodiments, a single plication is positioned adjacent the GEJ to form artificial tube 1250 or GERD treatment. According to othej embodiments, between about 5 and about 8 plications are positioned adjacent each othelr to form artificial tube 1250. According to some embodiments, when artificial tube 125(1) is formed with between one and two tissue plications, artificial tube 1250 is about 1 cm in length. In other embodiments, when artificial tube 1250 includes between about 10 to about 20 tissue plications, artificial tube 1250 is about 10 cm in length. In some embodiments, the diameter of artificial tube 1250 is between about 0.2 cm and about 10 cm. In other embodiments, the diameter of artificial tube 1250 is between about 0.5 cm and about 5 cm. In some embodiments, the diameter of artificial tube 1250 is between about 0.5 cm and about 3 cm. In some embodiments, the diameter of artificial tube 1250 is between about 0.5 cm and about 2 cm.
[0052] According to another embodiment, an implant device 1306 can be implanted onto tissue 1302 with multiple attachments, as shown in FIGS. 13A and 13B. According to some embodiment as shown in FIG. 13 A, an implant 1306 can be located or held in position by coupling retractors 1304 A - 1304D to tissue 1302 and/or implant device 1306. In some embodiments, as shown in FIG. 13B, implant 1306 may be such a shape or dimension that multiple anchor implants are required for proper or secure attachment of implant 1306 to tissue 1302. As shown in FIG. 13B, multiple anchors 1308A - 1308D are implanted throu gh tissue 1302 and implant 1306 to affix implant 1306 as desired to tissue 1302. Acco ding to some embodiments, anchors 1308A - 1308D include pledgets 1310 and suture 1$12. According to some embodiments, pledgets 1310 and suture 1312 can be fabricated i|n accord with and from the materials of other pledgets and sutures described herein and incorporated herein by reference.
[0053] Referring mow to FIG. 14, anchor implant 1400 includes a coupling 1402 and pledgets 506 and 510 coupled together by suture 512. Anchor implant 1400 is configured to couple tissue 5θ|2, 504 to itself or to an implanted device. According to some embodiments, coujpling 1402 is configured to provide a site on anchor implant 1400 for attaching an implantable device, mechanical tool, drug eluding device, sensor, other device described or incorporated herein, combinations thereof, or the like. In some embodiments, coupling 1402 can be, but is not limited to a hook, clip, Velcro, magnet, loop, combinations thereof, or the like. According to some embodiments, coupling 1402 can be formed from a non-resorbable polymer, resorbable polymer, biodegradable polymer, drug eluding polymer, stainless steel, titanium, cobalt chromium, surgical material, combinations thereof, or the like.
[0054] According to another embodiment, as shown in FIG. 17, endoluminal surgical device 100 includes guide wire 1702 that includes tissue engaging retractor tip 1704. According to some embodiments, tissue engaging retractor tip 1704 is configured to releasable attach to tissue at a site near where an implant attachment site is targeted. In some embodiments, tissue engaging retractor tip 1704 can be, but is not limited to a corkscrew type design, screw threads, a hook, a loop, jaws, locking jaws, combinations thereof, and the like. In use, having a guide wire 1702 that can attach to tissue or target a tissue at or near an implant site can help direct where the implant device will pass and increases the efficiency and effectiveness of surgical procedures because the path that the device is require to pass is less rigorous and/or straighter.
[0055] Referring ψow to FIGS. 15A and 15B, an adjustable implantable device 1500 is shown. In some embodiments, adjustable implantable device 1500 includes anchor implants 1506 and! 1508, however, the number of anchor implants used in practice can vary to what is neέessary for a particular procedure being performed, corrected, or desired. In some embodiments, anchor implants include pledgets 1510 connected by suture 1512. In seme embodiments, anchor implant 1506 is coupled with adjustment mechanism 1514 lj>y suture 1516 and anchor implant 1508 is coupled with adjustment mechanism 1514 by suture 1518. Adjustment mechanism 1514 is configured to adjust a physical parameter, such as for example, length, width, diameter, rotational axis, combinations therφof, or the like, in response to stimulation. In a preferred embodiment, adjustment mechanism 1514 linearly shortens in response to a predetermined stimulation. In some embodiments, a predetermined stimulation can be, but is not limited to, a radio frequency, ultra-sc und, mechanical force, pressure, direct mechanical manipulation, magnetic force, ch emical interaction, enzyme interaction, fluid, temperature, biological fluid, cellular interaction, cellular by-product, inter-cellular constituent, intra-cellular constituent, food, digestion by-product, time, combinations thereof, or the like.
[0056] In some embodiments, adjustable implant device 1500 is implanted into the tissue surrounding the gastro-esophageal-junction (GEJ). Having the adjustable implant device 1500 implanted in or near the GEJ allows the adjustable implant device 1500 to assist or augment the natural function of the GEJ. According to an embodiment, in a relaxed state adjustable implant device 1500 leaves the GEJ in an open state such that food, liquids, or the like can be passed from the esophagus into the stomach of a patient. However, following activation, adjustable mechanism 1514 shortens and, thereby, tightens the GEJ such that gastric fluids are blocked from passing from the stomach into the esophagus and causing or worsening a patient's GERD condition. In some embodiments, adjustable mechanism 1514 αan be a threaded mechanism, a coil mechanism, a spring mechanism, a magnetic mechanism, a ratchet mechanism, memory material, piezoelectric material, temperature sensitive material, combinations thereof, or the like.
[0057] In an alternative embodiment, adjustable implant device 1500 can be implanted in a stomach of a patjent. Implanting adjustable implant device 1500 into a stomach allows a patient or physician to reversibly and/or temporarily restrict the volume of the stomach of a patient in respjonse to a predetermined stimulus. According to some embodiments adjustable implant! device 1500, when implanted in the stomach of a patient, can be retracted or adjusted prior to consuming food and thereby act as a temporary gastric restriction device. In some embodiments, adjustable implant device 1500 can be configured to respond to a digestive by-product, a cellular excretion, particular gastric fluids, an external stimulation, combinations thereof, or the like. It will be appreciated that adjustable iirψlant device 1500 can be implanted in many locations in a patient, such as but not limited to, any sphincter, tubular organ such as the intestine, muscle, skeletal system, combinatipns thereof, or the like.
[0058] Referring ljiow to FIG. 16, a surgical stabilization system is shown. According to some surgical procedures a surgical device needs to be inserted through tissue, a tissue wall such as an abdominal wall, an organ wall such as the stomach, or the like. Often, when performing $uch surgical procedures a surgeon loses much control over a working end of a surgical instrument after the instrument has been passed through the tissue wall.
Figure imgf000019_0001
embodiments, mo^e or less stabilizers can be utilized depending the requirements of particular situation. For simplicity sake only one stabilizer will be described, however, it will be appreciated that each stabilizer includes generally the same construction. According to somφ embodiments, a stabilizer, such as stabilizer 1406 for example, includes a tissue anchor end and a device anchor end. The tissue anchor end includes pledgets 1416 and 1417 connected by suture material 1418. Pledgets 1416 and 1417 and suture material 1418 can be implanted according to methods and with devices disclosed herein or incorporated herein by reference. Pledget 1417 is further connected to line 1420 that extends from pledget 1417 to device 102. Line 1420 can be, but is not limited to, suture material, wire, rods, k-wires, t-bars, or other surgical material or devices that can support tension, pressure, and/or torque. According to some embodiments, the device anchoring end of stabilization 1418 can be configured to couple to an attachment on device 102 such that a force applied to stabilizer 1418 can be translated to device 102 and/or manipulation force applied to device 102 can be leveraged over and around stabilization 1418., It will be appreciated that stabilization devices can be implanted as desired to assist in manipulating surgical device 102.

Claims

WHAT IS CLAIMED IS:
1. An implan|t device, comprising: a medical jmplant configured to be implanted into a lumen of a body without creating an incisiofn in skin; the medica)l implant being configured to maintain a plication in a wall of the lumen; wherein the medical implant applies a medical treatment to the body after implantation.
2. The implant of claim 1, wherein the medical implant comprises a member selected from the group consisting of a drug delivery device, a time released drug delivery device, a coating, a biological stimulation device, a monitoring device, a feeding tube, a bioresorbable material, and combinations thereof.
3. The implant of claim 1, wherein the medical treatment includes material selected from the group consisting of radioactive material, chemotherapy material, biological material, and combinations thereof.
4. The implant of claim 1, wherein the medical implant comprises bioresorbable material including a drug.
5. An endoscopic treatment method, comprising: introducing an endoscopic device into a lumen of a patient without creating an incision in the patient's skin; engaging a wall of the lumen with an end effecter of the endoscopic device to form a plication; and activating the end effecter to secure the plication with an anchor object and a treatment device, wherein the treatment device is coupled with the anchor object, wherein the treatment device applies a medical treatment to the patient after the plication is secured.
6. The method of claim 5, wherein the treatment device includes a drug delivery device.
7. The method of claim 5, wherein the treatment device includes material selected from the group consisting of radioactive material, chemotherapy material, biological material, and combinations thereof.
8. The method of claim 5, wherein the treatment device includes a bioresorbable material including a drug.
9. An endoscopic treatment method, comprising: introducing an endoscopic device into a body cavity of a patient without creating an incision in the patient's skin; introducing a treatment device into the cavity; engaging a wall of the cavity with an end effecter of the endoscopic device; forming a plication in the wall of the cavity such that an open pocket is formed in the wall of the cavity; and coupling an implant device with the plication, wherein the implant device delivers a drug to the patient.
10. An endoscopic treatment method, comprising: introducing an endoscopic device into a lumen of a patient without creating an incision in the patient's skin; introducing a treatment device into the lumen; engaging aj wall of the lumen with an end effecter of the endoscopic device; and forming a plication in the wall of the lumen such that an open pocket is formed in the wall of the lun|en.
11. The method of claim 10, further comprising forming an artificial biological tube by forming multiple plications such that open pockets formed by the multiple plications are axially aligned.
12. The method of claim 10, further comprising: forming a $econd plication in the wall of the lumen such that a second open pocket is formed iri the wall of the lumen, wherein the plications are adjacent, and wherein the open pockets are axially aligned; and coupling th1 e plication with the second plication.
13. The method of claim 10, further comprising: forming a $econd plication in the wall of the lumen adjacent the first plication; and coupling the first plication with the second plication to thereby form a first double plication; wherein thb open pocket is formed between the first plication and the second plication.
14. An endoscopic GERD treatment method, comprising: introducing an endoscopic device into a lumen of a patient without creating an incision in the patient's skin; engaging a wall of the lumen with an end effecter of the endoscopic device; forming a plication in the wall of the lumen near the patient's gastro-esophageal- j unction such that an artificial biologic tube is formed distal to the gastroesophageal - junction to block gastric fluid from interfering with tissue of the patient's esophagus.
15. An endoscopic obesity treatment method, comprising: introducing an endoscopic device into a stomach of a patient without creating an incision in the patient's skin; engaging aj wall of the stomach with an end effecter of the endoscopic device; forming a plication in the wall of the stomach such that an artificial biologic tube is formed within tψe stomach of the patient, thereby reducing a volume of the stomach to treat obesity.
16. An endoscopic treatment method, comprising: introducing an endoscopic device into a lumen of a patient without creating an incision in the patient's skin; introducing a treatment device into the lumen; engaging aj wall of the lumen with an end effecter of the endoscopic device; forming at least one first plication in the wall of the lumen; forming at least one second plication in the wall of the lumen adjacent the first plication; coupling the first plication with the second plication to thereby form at least one first double plication; wherein an open pocket is formed between the first plication and the second plication; wherein the double plication is positioned in cooperative relationship with the patient's gastro-esophageal -junction so as to form an artificial gastric valve.
17. An endoscopic treatment method, comprising: introducing an endoscopic device into a lumen of a patient without creating an incision in the patient's skin; introducing a treatment device into the lumen; engaging a wall of the lumen with an end effecter of the endoscopic device; forming at least one first plication in the wall of the lumen; forming at least one second plication in the wall of the lumen adjacent the first plication; coupling the first plication with the second plication to thereby form at least one first double plication, wherein an open pocket is formed between the first plication and the second plication; and coupling an implant device with the first or second plication.
18. The method of claim 17, wherein the implant device is a drug delivery device.
19. An endoscopic treatment method, comprising: introducing an endoscopic device into a lumen of a patient without creating an incision in the patient's skin; introducing a treatment device into the lumen; engaging a( wall of the lumen with an end effecter of the endoscopic device; forming at least first and second plications in the wall of the lumen such that at least first and seccnd open pockets are formed in the wall of the lumen; wherein th plications are adjacent, and wherein the open pockets are axially aligned.
20. An endosc 3pic treatment method, comprising: introducing an endoscopic device into a lumen of a patient without creating an incision in the patient; introducing a treatment device into the lumen; engaging a wall of the lumen with a tissue grasper inserted into the lumen; forming a plication in the wall of the lumen with the tissue grasper; and anchoring the plication with an anchor object such that an open pocket is formed in the wall of the lumen.
21. A system for endoscopic treatment, comprising: an endoscopic device configured and dimensioned to be introduced into a lumen of a patient without creating an incision in the patient; a tissue grasper configured to engage a wall of the lumen from within the lumen and to form a plication in the wall; and an anchor Object configured to anchor the plication such that an open pocket is formed in the wall.
22. A medical |implant apparatus, comprising: an anchor (bbject configured to couple with tissue; and an adjustable mechanism configured to interact with the anchor object such as to apply alternative fprces upon the anchor object in response to a stimulus.
23. The implaitt of claim 22, wherein the adjustable mechanism includes a member selected from the ^roup consisting of: piezoelectric material, magnetic material, screw- threads, a spring, a memory metal, elastic material, a mechanical mechanism, a temperature sensitive material, and combinations thereof.
24. The implant of claim 22, wherein the stimulus is selected from the group consisting of: a radio frequency, ultra-sound, a mechanical force, pressure, direct mechanical manipulation, a magnetic force, a chemical interaction, enzyme interaction, a fluid, a temperature, a biological fluid, cellular interaction, a cellular by-product, an intercellular constituent, an intra-cellular constituent, food, a digestion by-product, a lapse of time, and combinations thereof.
25. A method for temporary tissue restructuring, comprising: implanting] an ancnor object onto tissue to be adjustably restructured; associating! an adjustable mechanism with the anchor object such that a force generated by the adjustable mechanism can change a position of the anchor object with respect to the adjustable mechanism, and thereby restructure the tissue; and stimulating the adjustable mechanism to generate the force.
26. The method of claim 25, further comprising shortening the adjustable mechanism in response to a stimulus and thereby resulting in a distance between the adjustable mechanism and the anchor object reducing such as to tighten tissue between the anchor object and the adjustable mechanism.
27. A method of φanipulating a surgical tool, comprising: forming anj incision in body tissue; attaching a| manipulation line to body tissue near the incision; introducind ^e surgical to°l through the incision in the body tissue; attaching a|free end of the manipulation line to the surgical tool; and manipulating the surgical tool to perform a medical treatment procedure.
28. The method of claim 27, wherein the manipulation line at least partially supports the surgical tool.
29. The method of claim 27, further comprising applying tension, pressure, or torque to the manipulation ljne.
30. A surgical toojl support system, comprising: an elongate member configured for insertion into a body cavity; an anchor φbject configured and dimensioned to be manipulated by said elongated member to be attached to a body tissue within said cavity; and a manipulation line extending from the anchor object and configured and dimensioned to extend outside said body cavity for manipulation of tissue secured by the anchor object.
PCT/US2007/080485 2006-10-04 2007-10-04 Devices and methods for endoluminal gastric restriction tissue manipulation, and drug delivery WO2008043044A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP07843869A EP2076183A4 (en) 2006-10-04 2007-10-04 Devices and methods for endoluminal gastric restriction tissue manipulation, and drug delivery
CN200780041843.4A CN101795627A (en) 2006-10-04 2007-10-04 Devices and methods for endoluminal gastric restriction tissue manipulation, and drug delivery

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84941406P 2006-10-04 2006-10-04
US60/849,414 2006-10-04

Publications (3)

Publication Number Publication Date
WO2008043044A2 true WO2008043044A2 (en) 2008-04-10
WO2008043044A3 WO2008043044A3 (en) 2008-06-05
WO2008043044A8 WO2008043044A8 (en) 2008-08-07

Family

ID=39269231

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/080485 WO2008043044A2 (en) 2006-10-04 2007-10-04 Devices and methods for endoluminal gastric restriction tissue manipulation, and drug delivery

Country Status (4)

Country Link
US (6) US8166978B2 (en)
EP (2) EP2258277A1 (en)
CN (1) CN101795627A (en)
WO (1) WO2008043044A2 (en)

Cited By (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7976554B2 (en) 2006-04-19 2011-07-12 Vibrynt, Inc. Devices, tools and methods for performing minimally invasive abdominal surgical procedures
US8342183B2 (en) 2006-04-19 2013-01-01 Vibrynt, Inc. Devices and methods for treatment of obesity
US8382775B1 (en) 2012-01-08 2013-02-26 Vibrynt, Inc. Methods, instruments and devices for extragastric reduction of stomach volume
US8556925B2 (en) 2007-10-11 2013-10-15 Vibrynt, Inc. Devices and methods for treatment of obesity
US8585733B2 (en) 2006-04-19 2013-11-19 Vibrynt, Inc Devices, tools and methods for performing minimally invasive abdominal surgical procedures
US8834492B2 (en) 2005-05-20 2014-09-16 Neotract, Inc. Continuous indentation lateral lobe apparatus and method
US8888799B2 (en) 2005-05-20 2014-11-18 Neotract, Inc. Coiled anchor device
US8900252B2 (en) 2005-05-20 2014-12-02 Neotract, Inc. Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US8936609B2 (en) 2005-05-20 2015-01-20 Neotract, Inc. Apparatus and method for manipulating or retracting tissue and anatomical structure
US8939996B2 (en) 2005-05-20 2015-01-27 Neotract, Inc. Anchor delivery System
US8940001B2 (en) 2005-05-20 2015-01-27 Neotract, Inc. Devices, systems and methods for retracting, lifting, compressing, supporting or repositioning tissues or anatomical structures
US8945152B2 (en) 2005-05-20 2015-02-03 Neotract, Inc. Multi-actuating trigger anchor delivery system
US8992547B2 (en) 2012-03-21 2015-03-31 Ethicon Endo-Surgery, Inc. Methods and devices for creating tissue plications
US9034001B2 (en) 2005-05-20 2015-05-19 Neotract, Inc. Slotted anchor device
US9113866B2 (en) 2011-12-15 2015-08-25 Ethicon Endo-Surgery, Inc. Devices and methods for endoluminal plication
US9113879B2 (en) 2011-12-15 2015-08-25 Ethicon Endo-Surgery, Inc. Devices and methods for endoluminal plication
US9149266B2 (en) 2005-05-20 2015-10-06 Neotract, Inc. Deforming anchor device
US9161749B2 (en) 2011-04-14 2015-10-20 Neotract, Inc. Method and apparatus for treating sexual dysfunction
US9314362B2 (en) 2012-01-08 2016-04-19 Vibrynt, Inc. Methods, instruments and devices for extragastric reduction of stomach volume
US9320511B2 (en) 2005-05-20 2016-04-26 Neotract, Inc. Multi-actuating trigger anchor delivery system
US9364212B2 (en) 2005-05-20 2016-06-14 Neotract, Inc. Suture anchoring devices and methods for use
US9402711B2 (en) 2005-05-20 2016-08-02 Neotract, Inc. Median lobe band implant apparatus and method
US9486203B2 (en) 2005-05-20 2016-11-08 Neotract, Inc. Latching anchor device
US9504461B2 (en) 2005-05-20 2016-11-29 Neotract, Inc. Anchor delivery system
US9549739B2 (en) 2005-05-20 2017-01-24 Neotract, Inc. Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US10130353B2 (en) 2012-06-29 2018-11-20 Neotract, Inc. Flexible system for delivering an anchor
US10195014B2 (en) 2005-05-20 2019-02-05 Neotract, Inc. Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US10292801B2 (en) 2012-03-29 2019-05-21 Neotract, Inc. System for delivering anchors for treating incontinence
US10299780B2 (en) 2005-05-20 2019-05-28 Neotract, Inc. Apparatus and method for manipulating or retracting tissue and anatomical structure
US10426509B2 (en) 2005-05-20 2019-10-01 Neotract, Inc. Median lobe destruction apparatus and method
US10925587B2 (en) 2005-05-20 2021-02-23 Neotract, Inc. Anchor delivery system
US11298115B2 (en) 2020-08-03 2022-04-12 Teleflex Life Sciences Limited Handle and cartridge system for medical interventions
US11672520B2 (en) 2017-12-23 2023-06-13 Teleflex Life Sciences Limited Expandable tissue engagement apparatus and method

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6387104B1 (en) 1999-11-12 2002-05-14 Scimed Life Systems, Inc. Method and apparatus for endoscopic repair of the lower esophageal sphincter
US6592596B1 (en) 2000-05-10 2003-07-15 Scimed Life Systems, Inc. Devices and related methods for securing a tissue fold
US7097665B2 (en) * 2003-01-16 2006-08-29 Synecor, Llc Positioning tools and methods for implanting medical devices
CN101810521B (en) 2001-08-27 2015-05-13 辛尼科有限责任公司 Satiation devices and methods
US6675809B2 (en) 2001-08-27 2004-01-13 Richard S. Stack Satiation devices and methods
US6845776B2 (en) * 2001-08-27 2005-01-25 Richard S. Stack Satiation devices and methods
US7146984B2 (en) * 2002-04-08 2006-12-12 Synecor, Llc Method and apparatus for modifying the exit orifice of a satiation pouch
US20040143342A1 (en) 2003-01-16 2004-07-22 Stack Richard S. Satiation pouches and methods of use
US20050247320A1 (en) 2003-10-10 2005-11-10 Stack Richard S Devices and methods for retaining a gastro-esophageal implant
US8206456B2 (en) 2003-10-10 2012-06-26 Barosense, Inc. Restrictive and/or obstructive implant system for inducing weight loss
WO2005105003A1 (en) 2004-04-26 2005-11-10 Synecor, Llc Restrictive and/or obstructive implant for inducing weight loss
JP4856082B2 (en) 2004-10-15 2012-01-18 ビーエフケイダブリュ・エルエルシー Obesity device
US9055942B2 (en) 2005-10-03 2015-06-16 Boston Scienctific Scimed, Inc. Endoscopic plication devices and methods
US20080190989A1 (en) * 2005-10-03 2008-08-14 Crews Samuel T Endoscopic plication device and method
US9314361B2 (en) * 2006-09-15 2016-04-19 Boston Scientific Scimed, Inc. System and method for anchoring stomach implant
US8166978B2 (en) * 2006-10-04 2012-05-01 Ethicon Endo-Surgery, Inc. Methods and systems for manipulating tissue
US8529431B2 (en) 2007-02-14 2013-09-10 Bfkw, Llc Bariatric device and method
US8020741B2 (en) 2008-03-18 2011-09-20 Barosense, Inc. Endoscopic stapling devices and methods
US7934631B2 (en) 2008-11-10 2011-05-03 Barosense, Inc. Multi-fire stapling systems and methods for delivering arrays of staples
US20100276469A1 (en) * 2009-05-01 2010-11-04 Barosense, Inc. Plication tagging device and method
US8961539B2 (en) * 2009-05-04 2015-02-24 Boston Scientific Scimed, Inc. Endoscopic implant system and method
US8617167B2 (en) * 2009-12-04 2013-12-31 Pivot Medical, Inc. Methods and devices for accessing and retracting a capsule of a joint
US9044606B2 (en) 2010-01-22 2015-06-02 Ethicon Endo-Surgery, Inc. Methods and devices for activating brown adipose tissue using electrical energy
US8476227B2 (en) 2010-01-22 2013-07-02 Ethicon Endo-Surgery, Inc. Methods of activating a melanocortin-4 receptor pathway in obese subjects
WO2012092057A1 (en) 2010-12-29 2012-07-05 Ethicon Endo-Surgery, Inc. Methods and devices for activating brown adipose tissue with light
US9610429B2 (en) 2010-12-29 2017-04-04 Ethicon Endo-Surgery, Inc. Methods and devices for activating brown adipose tissue with targeted substance delivery
WO2013026473A1 (en) 2011-08-23 2013-02-28 Ethicon Endo-Surgery, Inc. Devices and methods for anchoring an endoluminal sleeve in the gi tract
US9149383B2 (en) 2012-01-23 2015-10-06 Apollo Endosurgery, Inc. Endolumenal esophageal restriction device
US9456916B2 (en) 2013-03-12 2016-10-04 Medibotics Llc Device for selectively reducing absorption of unhealthy food
US9011365B2 (en) 2013-03-12 2015-04-21 Medibotics Llc Adjustable gastrointestinal bifurcation (AGB) for reduced absorption of unhealthy food
US9067070B2 (en) 2013-03-12 2015-06-30 Medibotics Llc Dysgeusia-inducing neurostimulation for modifying consumption of a selected nutrient type
US10080884B2 (en) 2014-12-29 2018-09-25 Ethicon Llc Methods and devices for activating brown adipose tissue using electrical energy
US10092738B2 (en) 2014-12-29 2018-10-09 Ethicon Llc Methods and devices for inhibiting nerves when activating brown adipose tissue
US10653409B2 (en) 2015-12-04 2020-05-19 Crossroads Extremity Systems, Llc Devices and methods for anchoring tissue
US11097115B2 (en) * 2018-09-24 2021-08-24 Galvani Bioelectronics Limited Implantable pulse generator with suture holes and methods for implanting the same
CN113677297A (en) * 2019-03-11 2021-11-19 Bfkw有限公司 Single component intraluminal device and fixation method
WO2023179576A1 (en) * 2022-03-21 2023-09-28 南微医学科技股份有限公司 Anchoring device and anchoring instrument

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060161185A1 (en) 2005-01-14 2006-07-20 Usgi Medical Inc. Methods and apparatus for transmitting force to an end effector over an elongate member

Family Cites Families (90)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4938760A (en) 1989-03-29 1990-07-03 American Medical Systems, Inc. Female suspension procedure
CA2106236A1 (en) * 1992-09-23 1994-03-24 Jude S. Sauer Apparatus and method for anchoring surgical instrumentation
US5556428A (en) 1993-09-29 1996-09-17 Shah; Mrugesh K. Apparatus and method for promoting growth and repair of soft tissue
US5649960A (en) 1995-02-03 1997-07-22 Pavletic; Michael M. Apparatus and method for accelerating the stretching of skin
US5618270A (en) 1995-05-26 1997-04-08 Orejola; Wilmo C. Transthoracic aortic sleeve
US5893856A (en) * 1996-06-12 1999-04-13 Mitek Surgical Products, Inc. Apparatus and method for binding a first layer of material to a second layer of material
US5861003A (en) * 1996-10-23 1999-01-19 The Cleveland Clinic Foundation Apparatus and method for occluding a defect or aperture within body surface
CA2224366C (en) * 1996-12-11 2006-10-31 Ethicon, Inc. Meniscal repair device
US5944738A (en) 1998-02-06 1999-08-31 Aga Medical Corporation Percutaneous catheter directed constricting occlusion device
US6352503B1 (en) 1998-07-17 2002-03-05 Olympus Optical Co., Ltd. Endoscopic surgery apparatus
JP2000300571A (en) * 1999-04-19 2000-10-31 Nissho Corp Closure plug for transcatheter operation
US6506196B1 (en) 1999-06-22 2003-01-14 Ndo Surgical, Inc. Device and method for correction of a painful body defect
US8287554B2 (en) * 1999-06-22 2012-10-16 Ethicon Endo-Surgery, Inc. Method and devices for tissue reconfiguration
US6663639B1 (en) 1999-06-22 2003-12-16 Ndo Surgical, Inc. Methods and devices for tissue reconfiguration
US6835200B2 (en) 1999-06-22 2004-12-28 Ndo Surgical. Inc. Method and devices for tissue reconfiguration
US6494888B1 (en) 1999-06-22 2002-12-17 Ndo Surgical, Inc. Tissue reconfiguration
US6821285B2 (en) * 1999-06-22 2004-11-23 Ndo Surgical, Inc. Tissue reconfiguration
US20040122456A1 (en) * 2002-12-11 2004-06-24 Saadat Vahid C. Methods and apparatus for gastric reduction
US8574243B2 (en) * 1999-06-25 2013-11-05 Usgi Medical, Inc. Apparatus and methods for forming and securing gastrointestinal tissue folds
US7416554B2 (en) 2002-12-11 2008-08-26 Usgi Medical Inc Apparatus and methods for forming and securing gastrointestinal tissue folds
US7160312B2 (en) 1999-06-25 2007-01-09 Usgi Medical, Inc. Implantable artificial partition and methods of use
US6626899B2 (en) * 1999-06-25 2003-09-30 Nidus Medical, Llc Apparatus and methods for treating tissue
US6120525A (en) * 1999-07-14 2000-09-19 Westcott; Mitchell S. Skin tensioning device
US6461292B1 (en) 1999-08-12 2002-10-08 Obtech Medical Ag Anal incontinence treatment with wireless energy supply
US7267679B2 (en) 1999-09-13 2007-09-11 Rex Medical, L.P Vascular hole closure device
US7942888B2 (en) * 1999-09-13 2011-05-17 Rex Medical, L.P. Vascular hole closure device
WO2001058364A1 (en) * 2000-02-09 2001-08-16 Eva Corporation Surgical fastener
US6470892B1 (en) * 2000-02-10 2002-10-29 Obtech Medical Ag Mechanical heartburn and reflux treatment
US6532503B1 (en) * 2000-02-18 2003-03-11 3Com Corporation Method and apparatus to detect lost buffers with a descriptor based queue
US7361185B2 (en) 2001-05-09 2008-04-22 Canica Design, Inc. Clinical and surgical system and method for moving and stretching plastic tissue
US8105351B2 (en) 2001-05-18 2012-01-31 C.R. Bard, Inc. Method of promoting tissue adhesion
US6616684B1 (en) 2000-10-06 2003-09-09 Myocor, Inc. Endovascular splinting devices and methods
US6723038B1 (en) * 2000-10-06 2004-04-20 Myocor, Inc. Methods and devices for improving mitral valve function
US20020138086A1 (en) 2000-12-06 2002-09-26 Robert Sixto Surgical clips particularly useful in the endoluminal treatment of gastroesophageal reflux disease (GERD)
US7035236B2 (en) * 2001-03-30 2006-04-25 Telcordia Technologies, Inc. Network-layer and link-layer use of shadow addresses with IP-based base stations
US7747322B2 (en) * 2001-05-01 2010-06-29 Intrapace, Inc. Digestive organ retention device
US7702394B2 (en) 2001-05-01 2010-04-20 Intrapace, Inc. Responsive gastric stimulator
US7020531B1 (en) * 2001-05-01 2006-03-28 Intrapace, Inc. Gastric device and suction assisted method for implanting a device on a stomach wall
US20050143760A1 (en) 2001-05-01 2005-06-30 Imran Mir A. Endoscopic gastric constriction device
US6535764B2 (en) * 2001-05-01 2003-03-18 Intrapace, Inc. Gastric treatment and diagnosis device and method
US6558400B2 (en) 2001-05-30 2003-05-06 Satiety, Inc. Obesity treatment tools and methods
US20050177180A1 (en) 2001-11-28 2005-08-11 Aptus Endosystems, Inc. Devices, systems, and methods for supporting tissue and/or structures within a hollow body organ
EP1467661A4 (en) * 2001-12-19 2008-11-05 Nmt Medical Inc Septal occluder and associated methods
US20030199974A1 (en) 2002-04-18 2003-10-23 Coalescent Surgical, Inc. Annuloplasty apparatus and methods
CA2485249A1 (en) 2002-05-09 2003-11-20 Thomas D. Egan Gastric bypass prosthesis
US6790214B2 (en) * 2002-05-17 2004-09-14 Esophyx, Inc. Transoral endoscopic gastroesophageal flap valve restoration device, assembly, system and method
US6746460B2 (en) 2002-08-07 2004-06-08 Satiety, Inc. Intra-gastric fastening devices
US7083630B2 (en) * 2002-08-29 2006-08-01 Scimed Life Systems, Inc. Devices and methods for fastening tissue layers
KR101050626B1 (en) * 2002-08-29 2011-07-19 미트랄 솔루션스, 인크. Implantation device for controlling the inner circumference of the anatomical orifice or lumen
US20040044364A1 (en) * 2002-08-29 2004-03-04 Devries Robert Tissue fasteners and related deployment systems and methods
WO2004021873A2 (en) 2002-09-06 2004-03-18 C.R. Bard, Inc. Integrated endoscope and accessory treatment device
US7149587B2 (en) * 2002-09-26 2006-12-12 Pacesetter, Inc. Cardiovascular anchoring device and method of deploying same
US9060844B2 (en) 2002-11-01 2015-06-23 Valentx, Inc. Apparatus and methods for treatment of morbid obesity
US7037344B2 (en) * 2002-11-01 2006-05-02 Valentx, Inc. Apparatus and methods for treatment of morbid obesity
US20060160085A1 (en) * 2002-11-08 2006-07-20 Timo Hillebrand Novel buffer formulations for isolating purifying and recovering long-chain and short-chain nucleic acids
WO2004050971A2 (en) * 2002-11-29 2004-06-17 Liddicoat John R Apparatus and method for manipulating tissue
US7025791B2 (en) 2002-12-02 2006-04-11 Gi Dynamics, Inc. Bariatric sleeve
US7200439B2 (en) * 2003-01-24 2007-04-03 Proteus Biomedical, Inc. Method and apparatus for enhancing cardiac pacing
US7780700B2 (en) * 2003-02-04 2010-08-24 ev3 Endovascular, Inc Patent foramen ovale closure system
US8216252B2 (en) 2004-05-07 2012-07-10 Usgi Medical, Inc. Tissue manipulation and securement system
WO2005020802A2 (en) 2003-09-02 2005-03-10 Creighton University Suturing devices and methods
WO2005034763A1 (en) 2003-09-11 2005-04-21 Nmt Medical, Inc. Devices, systems, and methods for suturing tissue
US20050247320A1 (en) * 2003-10-10 2005-11-10 Stack Richard S Devices and methods for retaining a gastro-esophageal implant
US20050080444A1 (en) 2003-10-14 2005-04-14 Kraemer Stefan J.M. Transesophageal gastric reduction device, system and method
US7054690B2 (en) * 2003-10-22 2006-05-30 Intrapace, Inc. Gastrointestinal stimulation device
US7361180B2 (en) 2004-05-07 2008-04-22 Usgi Medical, Inc. Apparatus for manipulating and securing tissue
US20050251189A1 (en) 2004-05-07 2005-11-10 Usgi Medical Inc. Multi-position tissue manipulation assembly
US8828025B2 (en) 2004-02-13 2014-09-09 Ethicon Endo-Surgery, Inc. Methods and devices for reducing hollow organ volume
MXPA06009971A (en) 2004-02-27 2007-08-08 Satiety Inc Methods and devices for reducing hollow organ volume.
US7703459B2 (en) * 2004-03-09 2010-04-27 Usgi Medical, Inc. Apparatus and methods for mapping out endoluminal gastrointestinal surgery
US7946976B2 (en) 2004-03-23 2011-05-24 Michael Gertner Methods and devices for the surgical creation of satiety and biofeedback pathways
WO2006049725A2 (en) * 2004-03-23 2006-05-11 Minimus Surgical Systems Surgical systems and devices to enhance gastric restriction therapies
US20050228415A1 (en) 2004-03-23 2005-10-13 Michael Gertner Methods and devices for percutaneous, non-laparoscopic treatment of obesity
US20060142790A1 (en) 2004-03-23 2006-06-29 Michael Gertner Methods and devices to facilitate connections between body lumens
US20050272977A1 (en) * 2004-04-14 2005-12-08 Usgi Medical Inc. Methods and apparatus for performing endoluminal procedures
US20050261713A1 (en) * 2004-04-27 2005-11-24 Hassan Ali H Methods and devices for producing turbulence in vascular blood flow
US7520884B2 (en) 2004-05-07 2009-04-21 Usgi Medical Inc. Methods for performing gastroplasty
US8057511B2 (en) * 2004-05-07 2011-11-15 Usgi Medical, Inc. Apparatus and methods for positioning and securing anchors
US7736374B2 (en) 2004-05-07 2010-06-15 Usgi Medical, Inc. Tissue manipulation and securement system
US20050251208A1 (en) 2004-05-07 2005-11-10 Usgi Medical Inc. Linear anchors for anchoring to tissue
US7390294B2 (en) * 2004-05-28 2008-06-24 Ethicon Endo-Surgery, Inc. Piezo electrically driven bellows infuser for hydraulically controlling an adjustable gastric band
US20060020277A1 (en) 2004-07-20 2006-01-26 Gostout Christopher J Gastric reshaping devices and methods
US20060020276A1 (en) * 2004-07-23 2006-01-26 Usgi Medical Inc. Apparatus and methods for achieving prolonged maintenance of gastrointestinal tissue folds
US7455681B2 (en) 2004-09-13 2008-11-25 Wound Care Technologies, Llc Wound closure product
US7686829B2 (en) 2004-11-04 2010-03-30 Wound Care Technologies, Inc. Wound closure product
US8087413B2 (en) * 2005-01-14 2012-01-03 Usgi Medical Inc. Attenuation of environmental parameters on a gastric lumen
US7878966B2 (en) 2005-02-04 2011-02-01 Boston Scientific Scimed, Inc. Ventricular assist and support device
JP4681908B2 (en) * 2005-02-14 2011-05-11 オリンパス株式会社 Surgical device controller and surgical system using the same
US7566298B2 (en) * 2006-04-25 2009-07-28 Nicholson Iv William Daniel Method of and apparatus for prevention of adjustable gastric band slips
US8166978B2 (en) * 2006-10-04 2012-05-01 Ethicon Endo-Surgery, Inc. Methods and systems for manipulating tissue

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060161185A1 (en) 2005-01-14 2006-07-20 Usgi Medical Inc. Methods and apparatus for transmitting force to an end effector over an elongate member

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP2076183A2

Cited By (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10492792B2 (en) 2005-05-20 2019-12-03 Neotract, Inc. Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US11090036B2 (en) 2005-05-20 2021-08-17 Neotract, Inc. Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US9486203B2 (en) 2005-05-20 2016-11-08 Neotract, Inc. Latching anchor device
US10195014B2 (en) 2005-05-20 2019-02-05 Neotract, Inc. Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US9504461B2 (en) 2005-05-20 2016-11-29 Neotract, Inc. Anchor delivery system
US10105132B2 (en) 2005-05-20 2018-10-23 Neotract, Inc. Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US8834492B2 (en) 2005-05-20 2014-09-16 Neotract, Inc. Continuous indentation lateral lobe apparatus and method
US8888799B2 (en) 2005-05-20 2014-11-18 Neotract, Inc. Coiled anchor device
US8900252B2 (en) 2005-05-20 2014-12-02 Neotract, Inc. Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US8936609B2 (en) 2005-05-20 2015-01-20 Neotract, Inc. Apparatus and method for manipulating or retracting tissue and anatomical structure
US8939996B2 (en) 2005-05-20 2015-01-27 Neotract, Inc. Anchor delivery System
US8940001B2 (en) 2005-05-20 2015-01-27 Neotract, Inc. Devices, systems and methods for retracting, lifting, compressing, supporting or repositioning tissues or anatomical structures
US8945152B2 (en) 2005-05-20 2015-02-03 Neotract, Inc. Multi-actuating trigger anchor delivery system
US11504149B2 (en) 2005-05-20 2022-11-22 Teleflex Life Sciences Limited Median lobe destruction apparatus and method
US9034001B2 (en) 2005-05-20 2015-05-19 Neotract, Inc. Slotted anchor device
US10265061B2 (en) 2005-05-20 2019-04-23 Neotract, Inc. Latching anchor device
US11471148B2 (en) 2005-05-20 2022-10-18 Teleflex Life Sciences Limited Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US10143461B2 (en) 2005-05-20 2018-12-04 Neotract, Inc. Devices, systems and methods for retracting, lifting, compressing, supporting or repositioning tissues or anatomical structures
US10945719B2 (en) 2005-05-20 2021-03-16 Neotract, Inc. Devices, systems and methods for retracting, lifting, compressing, supporting or repositioning tissues or anatomical structures
US10925587B2 (en) 2005-05-20 2021-02-23 Neotract, Inc. Anchor delivery system
US9149266B2 (en) 2005-05-20 2015-10-06 Neotract, Inc. Deforming anchor device
US10575844B2 (en) 2005-05-20 2020-03-03 Neotract, Inc. Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US10299780B2 (en) 2005-05-20 2019-05-28 Neotract, Inc. Apparatus and method for manipulating or retracting tissue and anatomical structure
US10426509B2 (en) 2005-05-20 2019-10-01 Neotract, Inc. Median lobe destruction apparatus and method
US9549739B2 (en) 2005-05-20 2017-01-24 Neotract, Inc. Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US9320511B2 (en) 2005-05-20 2016-04-26 Neotract, Inc. Multi-actuating trigger anchor delivery system
US9364212B2 (en) 2005-05-20 2016-06-14 Neotract, Inc. Suture anchoring devices and methods for use
US9402711B2 (en) 2005-05-20 2016-08-02 Neotract, Inc. Median lobe band implant apparatus and method
US7976554B2 (en) 2006-04-19 2011-07-12 Vibrynt, Inc. Devices, tools and methods for performing minimally invasive abdominal surgical procedures
US8342183B2 (en) 2006-04-19 2013-01-01 Vibrynt, Inc. Devices and methods for treatment of obesity
US8585733B2 (en) 2006-04-19 2013-11-19 Vibrynt, Inc Devices, tools and methods for performing minimally invasive abdominal surgical procedures
US8460321B2 (en) 2006-04-19 2013-06-11 Vibrynt, Inc. Devices, tools and methods for performing minimally invasive abdominal surgical procedures
US8556925B2 (en) 2007-10-11 2013-10-15 Vibrynt, Inc. Devices and methods for treatment of obesity
US9161749B2 (en) 2011-04-14 2015-10-20 Neotract, Inc. Method and apparatus for treating sexual dysfunction
US9113866B2 (en) 2011-12-15 2015-08-25 Ethicon Endo-Surgery, Inc. Devices and methods for endoluminal plication
US9173657B2 (en) 2011-12-15 2015-11-03 Ethicon Endo-Surgery, Inc. Devices and methods for endoluminal plication
US9113879B2 (en) 2011-12-15 2015-08-25 Ethicon Endo-Surgery, Inc. Devices and methods for endoluminal plication
US9113868B2 (en) 2011-12-15 2015-08-25 Ethicon Endo-Surgery, Inc. Devices and methods for endoluminal plication
US10292703B2 (en) 2011-12-15 2019-05-21 Ethicon Endo-Surgery, Inc. Devices and methods for endoluminal plication
US9113867B2 (en) 2011-12-15 2015-08-25 Ethicon Endo-Surgery, Inc. Devices and methods for endoluminal plication
US9119615B2 (en) 2011-12-15 2015-09-01 Ethicon Endo-Surgery, Inc. Devices and methods for endoluminal plication
US10687808B2 (en) 2011-12-15 2020-06-23 Ethicon Endo-Surgery, Inc. Devices and methods for endoluminal plication
US9314362B2 (en) 2012-01-08 2016-04-19 Vibrynt, Inc. Methods, instruments and devices for extragastric reduction of stomach volume
US9155528B2 (en) 2012-01-08 2015-10-13 Vibrynt, Inc. Methods, instruments and devices for extragastic reduction of stomach volume
US8382775B1 (en) 2012-01-08 2013-02-26 Vibrynt, Inc. Methods, instruments and devices for extragastric reduction of stomach volume
US10595852B2 (en) 2012-03-21 2020-03-24 Ethicon Llc Methods and devices for creating tissue plications
US9980716B2 (en) 2012-03-21 2018-05-29 Ethicon Llc Methods and devices for creating tissue plications
US8992547B2 (en) 2012-03-21 2015-03-31 Ethicon Endo-Surgery, Inc. Methods and devices for creating tissue plications
US10292801B2 (en) 2012-03-29 2019-05-21 Neotract, Inc. System for delivering anchors for treating incontinence
US10130353B2 (en) 2012-06-29 2018-11-20 Neotract, Inc. Flexible system for delivering an anchor
US11331093B2 (en) 2012-06-29 2022-05-17 Teleflex Life Sciences Limited Flexible system for delivering an anchor
US10912637B2 (en) 2013-03-14 2021-02-09 Neotract, Inc. Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US11850140B2 (en) 2013-03-14 2023-12-26 Teleflex Life Sciences Limited Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US10349932B2 (en) 2013-03-15 2019-07-16 Neotract, Inc. Anchor delivery system
US11129608B2 (en) 2013-03-15 2021-09-28 Neotract, Inc. Anchor delivery system
US11672520B2 (en) 2017-12-23 2023-06-13 Teleflex Life Sciences Limited Expandable tissue engagement apparatus and method
US11298115B2 (en) 2020-08-03 2022-04-12 Teleflex Life Sciences Limited Handle and cartridge system for medical interventions
US11801041B2 (en) 2020-08-03 2023-10-31 Teleflex Life Sciences Limited Handle and cartridge system for medical interventions

Also Published As

Publication number Publication date
US20090018558A1 (en) 2009-01-15
US8926641B2 (en) 2015-01-06
US8469976B2 (en) 2013-06-25
US20080243144A1 (en) 2008-10-02
US8882789B2 (en) 2014-11-11
EP2076183A2 (en) 2009-07-08
EP2258277A1 (en) 2010-12-08
US20090018389A1 (en) 2009-01-15
CN101795627A (en) 2010-08-04
WO2008043044A3 (en) 2008-06-05
US20080312729A1 (en) 2008-12-18
US8166978B2 (en) 2012-05-01
US8209037B2 (en) 2012-06-26
EP2076183A4 (en) 2009-09-16
WO2008043044A8 (en) 2008-08-07
US20090018594A1 (en) 2009-01-15
US20080312750A1 (en) 2008-12-18

Similar Documents

Publication Publication Date Title
US8469976B2 (en) Methods of organ reconfiguration
US7988617B2 (en) Extragastric minimally invasive methods and devices to treat obesity
EP2004243A2 (en) Devices and methods for endoluminal gastric restriction and tissue manipulation
US7841978B2 (en) Methods and devices for to treatment of obesity
US7963907B2 (en) Closed loop gastric restriction devices and methods
US8192349B2 (en) Medical device for changing the shape of hollow organs in the human
US20060264699A1 (en) Extragastric minimally invasive methods and devices to treat obesity
US20060195139A1 (en) Extragastric devices and methods for gastroplasty
US20110106129A1 (en) Methods and devices to treat obesity
EP2306942B1 (en) Gastric volume reduction using anterior to posterior wall junctions
US10646226B2 (en) Controlling a size of a pyloris
AU2011265332A1 (en) Devices and methods to treat a patient

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200780041843.4

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07843869

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase in:

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 1479/KOLNP/2009

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 2007843869

Country of ref document: EP